| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | antigen binding | IGKV1-39 IGKV1-17 IGKV1-16 ABO HLA-A HLA-C HLA-H IGKV1-5 IGKV2D-28 IGKV1D-39 IGKV1D-33 IGKV1D-12 IGKV2-30 | 6.26e-13 | 190 | 80 | 13 | GO:0003823 |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | SCN11A SLC13A3 SLC1A1 SLC1A3 SLC5A2 SLC5A4 SLC5A11 CNNM4 SLC10A5 CACNA1H | 1.60e-09 | 171 | 80 | 10 | GO:0015081 |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 2.54e-08 | 119 | 80 | 8 | GO:0015294 | |
| GeneOntologyMolecularFunction | solute:sodium symporter activity | 3.47e-08 | 81 | 80 | 7 | GO:0015370 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | CACNA1B SCN11A CNNM2 SLC13A3 SLC1A1 SLC1A3 SLC5A2 SLC5A4 SLC5A11 LRRC55 CNNM4 SLC10A5 CACNA1H | 3.82e-08 | 465 | 80 | 13 | GO:0046873 |
| GeneOntologyMolecularFunction | beta-2-microglobulin binding | 1.15e-07 | 12 | 80 | 4 | GO:0030881 | |
| GeneOntologyMolecularFunction | symporter activity | 1.54e-07 | 150 | 80 | 8 | GO:0015293 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | CACNA1B SCN11A CNNM2 SLC13A3 SLC1A1 SLC1A3 SLC2A4 SLC5A2 SLC5A4 SLC5A11 LRRC55 CNNM4 SLC10A5 CACNA1H | 1.75e-07 | 627 | 80 | 14 | GO:0022890 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | CACNA1B SCN11A CNNM2 SLC13A3 SLC1A1 SLC1A3 SLC2A4 SLC5A2 SLC5A4 SLC5A11 LRRC55 CNNM4 SLC10A5 CACNA1H | 3.50e-07 | 664 | 80 | 14 | GO:0008324 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | CACNA1B SCN11A CNNM2 ANXA6 SLC13A3 SLC1A1 SLC1A3 SLC2A4 SLC5A2 SLC5A4 SLC5A11 LRRC55 CNNM4 SLC10A5 CACNA1H | 5.05e-07 | 793 | 80 | 15 | GO:0015075 |
| GeneOntologyMolecularFunction | carbohydrate:monoatomic cation symporter activity | 5.46e-07 | 17 | 80 | 4 | GO:0005402 | |
| GeneOntologyMolecularFunction | T cell receptor binding | 1.10e-06 | 20 | 80 | 4 | GO:0042608 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | CACNA1B SCN11A CNNM2 SLC13A3 SLC1A1 SLC1A3 SLC2A4 SLC5A2 SLC5A4 SLC5A11 LRRC55 CNNM4 SLC10A5 CACNA1H | 1.69e-06 | 758 | 80 | 14 | GO:0015318 |
| GeneOntologyMolecularFunction | D-glucose:sodium symporter activity | 2.14e-06 | 7 | 80 | 3 | GO:0005412 | |
| GeneOntologyMolecularFunction | hexose transmembrane transporter activity | 2.83e-06 | 25 | 80 | 4 | GO:0015149 | |
| GeneOntologyMolecularFunction | D-glucose transmembrane transporter activity | 2.83e-06 | 25 | 80 | 4 | GO:0055056 | |
| GeneOntologyMolecularFunction | monosaccharide transmembrane transporter activity | 3.91e-06 | 27 | 80 | 4 | GO:0015145 | |
| GeneOntologyMolecularFunction | CD8 receptor binding | 5.11e-06 | 9 | 80 | 3 | GO:0042610 | |
| GeneOntologyMolecularFunction | TAP complex binding | 5.11e-06 | 9 | 80 | 3 | GO:0062061 | |
| GeneOntologyMolecularFunction | sugar transmembrane transporter activity | 5.26e-06 | 29 | 80 | 4 | GO:0051119 | |
| GeneOntologyMolecularFunction | TAP1 binding | 7.28e-06 | 10 | 80 | 3 | GO:0046978 | |
| GeneOntologyMolecularFunction | TAP2 binding | 7.28e-06 | 10 | 80 | 3 | GO:0046979 | |
| GeneOntologyMolecularFunction | TAP binding | 7.28e-06 | 10 | 80 | 3 | GO:0046977 | |
| GeneOntologyMolecularFunction | transporter activity | CACNA1B SCN11A CNNM2 AZGP1 ANXA6 APOF SLC13A3 SLC1A1 SLC1A3 SLC2A4 SLC5A2 SLC5A4 SLC5A11 LRRC55 CNNM4 SLC10A5 CACNA1H | 1.10e-05 | 1289 | 80 | 17 | GO:0005215 |
| GeneOntologyMolecularFunction | organic acid:sodium symporter activity | 1.14e-05 | 35 | 80 | 4 | GO:0005343 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | CACNA1B SCN11A CNNM2 AZGP1 ANXA6 SLC13A3 SLC1A1 SLC1A3 SLC2A4 SLC5A2 SLC5A4 SLC5A11 LRRC55 CNNM4 SLC10A5 CACNA1H | 1.49e-05 | 1180 | 80 | 16 | GO:0022857 |
| GeneOntologyMolecularFunction | carbohydrate transmembrane transporter activity | 2.38e-05 | 42 | 80 | 4 | GO:0015144 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | 2.44e-05 | 296 | 80 | 8 | GO:0015291 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | 2.75e-05 | 301 | 80 | 8 | GO:0022853 | |
| GeneOntologyMolecularFunction | natural killer cell lectin-like receptor binding | 4.04e-05 | 17 | 80 | 3 | GO:0046703 | |
| GeneOntologyMolecularFunction | low-affinity D-glucose:sodium symporter activity | 4.74e-05 | 3 | 80 | 2 | GO:0005362 | |
| GeneOntologyMolecularFunction | acidic amino acid transmembrane transporter activity | 6.72e-05 | 20 | 80 | 3 | GO:0015172 | |
| GeneOntologyMolecularFunction | high-affinity L-glutamate transmembrane transporter activity | 1.57e-04 | 5 | 80 | 2 | GO:0005314 | |
| GeneOntologyMolecularFunction | glutamate:sodium symporter activity | 1.57e-04 | 5 | 80 | 2 | GO:0015501 | |
| GeneOntologyMolecularFunction | MHC class I protein binding | 2.82e-04 | 32 | 80 | 3 | GO:0042288 | |
| GeneOntologyMolecularFunction | 14-3-3 protein binding | 6.35e-04 | 42 | 80 | 3 | GO:0071889 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | 6.43e-04 | 477 | 80 | 8 | GO:0022804 | |
| GeneOntologyMolecularFunction | L-aspartate transmembrane transporter activity | 6.99e-04 | 10 | 80 | 2 | GO:0015183 | |
| GeneOntologyMolecularFunction | peptide antigen binding | 9.99e-04 | 49 | 80 | 3 | GO:0042605 | |
| GeneOntologyMolecularFunction | glutamate binding | 1.40e-03 | 14 | 80 | 2 | GO:0016595 | |
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 1.40e-03 | 14 | 80 | 2 | GO:0008331 | |
| GeneOntologyMolecularFunction | C4-dicarboxylate transmembrane transporter activity | 1.61e-03 | 15 | 80 | 2 | GO:0015556 | |
| GeneOntologyMolecularFunction | L-glutamate transmembrane transporter activity | 1.61e-03 | 15 | 80 | 2 | GO:0005313 | |
| GeneOntologyMolecularFunction | MHC protein binding | 1.63e-03 | 58 | 80 | 3 | GO:0042287 | |
| GeneOntologyMolecularFunction | magnesium ion transmembrane transporter activity | 2.33e-03 | 18 | 80 | 2 | GO:0015095 | |
| GeneOntologyMolecularFunction | L-amino acid transmembrane transporter activity | 2.91e-03 | 71 | 80 | 3 | GO:0015179 | |
| GeneOntologyMolecularFunction | amino acid:sodium symporter activity | 3.80e-03 | 23 | 80 | 2 | GO:0005283 | |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 4.84e-03 | 26 | 80 | 2 | GO:0005248 | |
| GeneOntologyMolecularFunction | amino acid:monoatomic cation symporter activity | 6.00e-03 | 29 | 80 | 2 | GO:0005416 | |
| GeneOntologyMolecularFunction | dicarboxylic acid transmembrane transporter activity | 6.84e-03 | 31 | 80 | 2 | GO:0005310 | |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | 8.66e-03 | 105 | 80 | 3 | GO:0015171 | |
| GeneOntologyBiologicalProcess | immunoglobulin production | IGKV1-39 IGKV1-37 IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-13 IGKV1-12 IGKV1-9 IGKV1-6 TLR9 IGKV1-5 RIF1 IGKV2D-30 IGKV2D-29 IGKV2D-28 IGKV2D-26 IGKV1D-43 IGKV1D-42 IGKV1D-39 IGKV1D-37 IGKV1D-33 IGKV1D-17 IGKV1D-13 IGKV1D-12 IGKV1D-8 IGKV2-40 IGKV2-30 IGKV2-29 IGKV2-28 | 3.57e-33 | 241 | 97 | 29 | GO:0002377 |
| GeneOntologyBiologicalProcess | production of molecular mediator of immune response | IGKV1-39 IGKV1-37 IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-13 IGKV1-12 IGKV1-9 IGKV1-6 HLA-A MR1 TLR9 IGKV1-5 RIF1 IGKV2D-30 IGKV2D-29 IGKV2D-28 IGKV2D-26 IGKV1D-43 IGKV1D-42 IGKV1D-39 IGKV1D-37 IGKV1D-33 IGKV1D-17 IGKV1D-13 IGKV1D-12 IGKV1D-8 IGKV2-40 IGKV2-30 IGKV2-29 IGKV2-28 | 2.18e-29 | 403 | 97 | 31 | GO:0002440 |
| GeneOntologyBiologicalProcess | adaptive immune response | IGKV1-39 IGKV1-37 IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-13 SERPINA3 IGKV1-12 TRAV8-1 IGKV1-9 IGKV1-6 HLA-A HLA-C HLA-H MR1 IGKV1-5 RIF1 LAT IGKV2D-30 IGKV2D-29 IGKV2D-28 IGKV2D-26 IGKV1D-43 IGKV1D-42 IGKV1D-39 IGKV1D-37 IGKV1D-33 IGKV1D-17 IGKV1D-13 IGKV1D-12 IGKV1D-8 IGKV2-40 IGKV2-30 IGKV2-29 IGKV2-28 | 2.75e-24 | 838 | 97 | 35 | GO:0002250 |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent | 5.55e-06 | 8 | 97 | 3 | GO:0002485 | |
| GeneOntologyBiologicalProcess | metal ion transport | CACNA1B SCN11A CNNM2 ANXA6 SLC13A3 TLR9 SLC1A1 SLC1A3 SLC5A2 SLC5A4 JPH1 SLC5A11 LRRC55 CNNM4 SLC10A5 CACNA1H | 1.62e-05 | 1000 | 97 | 16 | GO:0030001 |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen via MHC class I | 4.07e-05 | 41 | 97 | 4 | GO:0002474 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell mediated cytotoxicity | 4.49e-05 | 42 | 97 | 4 | GO:0001916 | |
| GeneOntologyBiologicalProcess | sodium ion transport | 4.68e-05 | 275 | 97 | 8 | GO:0006814 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent | 5.40e-05 | 16 | 97 | 3 | GO:0002486 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway | 6.54e-05 | 17 | 97 | 3 | GO:0002484 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class Ib | 6.54e-05 | 17 | 97 | 3 | GO:0002476 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen via MHC class Ib | 7.82e-05 | 18 | 97 | 3 | GO:0002428 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous peptide antigen via MHC class I | 7.82e-05 | 18 | 97 | 3 | GO:0042590 | |
| GeneOntologyBiologicalProcess | monoatomic cation transport | CACNA1B SCN11A CNNM2 ANXA6 SLC13A3 TLR9 SLC1A1 SLC1A3 SLC5A2 SLC5A4 JPH1 SLC5A11 LRRC55 CNNM4 SLC10A5 CACNA1H | 9.35e-05 | 1157 | 97 | 16 | GO:0006812 |
| GeneOntologyBiologicalProcess | regulation of T cell mediated cytotoxicity | 1.13e-04 | 53 | 97 | 4 | GO:0001914 | |
| GeneOntologyBiologicalProcess | aspartate transmembrane transport | 1.46e-04 | 22 | 97 | 3 | GO:0015810 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous antigen | 1.61e-04 | 58 | 97 | 4 | GO:0019884 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I | 1.67e-04 | 23 | 97 | 3 | GO:0019885 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen | 2.15e-04 | 25 | 97 | 3 | GO:0002483 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation via MHC class Ib | 2.15e-04 | 25 | 97 | 3 | GO:0002475 | |
| GeneOntologyBiologicalProcess | D-aspartate import across plasma membrane | 3.24e-04 | 6 | 97 | 2 | GO:0070779 | |
| GeneOntologyBiologicalProcess | D-aspartate transmembrane transport | 3.24e-04 | 6 | 97 | 2 | GO:0070777 | |
| GeneOntologyBiologicalProcess | T cell mediated cytotoxicity directed against tumor cell target | 3.24e-04 | 6 | 97 | 2 | GO:0002419 | |
| GeneOntologyBiologicalProcess | L-aspartate import across plasma membrane | 3.24e-04 | 6 | 97 | 2 | GO:0140009 | |
| GeneOntologyBiologicalProcess | T cell mediated cytotoxicity | 3.32e-04 | 70 | 97 | 4 | GO:0001913 | |
| GeneOntologyBiologicalProcess | C4-dicarboxylate transport | 3.37e-04 | 29 | 97 | 3 | GO:0015740 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | CACNA1B SCN11A CNNM2 SLC13A3 TLR9 SLC1A1 SLC1A3 SLC5A2 SLC5A4 JPH1 LRRC55 CNNM4 CACNA1H | 3.76e-04 | 922 | 97 | 13 | GO:0098662 |
| GeneOntologyBiologicalProcess | positive regulation of T cell mediated immunity | 4.11e-04 | 74 | 97 | 4 | GO:0002711 | |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | 4.51e-04 | 208 | 97 | 6 | GO:0035725 | |
| GeneOntologyBiologicalProcess | regulation of synaptic vesicle transport | 4.53e-04 | 7 | 97 | 2 | GO:1902803 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous antigen | 4.53e-04 | 32 | 97 | 3 | GO:0019883 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen | 4.55e-04 | 76 | 97 | 4 | GO:0048002 | |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | CACNA1B SCN11A CNNM2 SLC13A3 TLR9 SLC1A1 SLC1A3 SLC5A2 SLC5A4 JPH1 LRRC55 CNNM4 CACNA1H | 4.61e-04 | 942 | 97 | 13 | GO:0098655 |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte mediated cytotoxicity | 5.27e-04 | 79 | 97 | 4 | GO:0001912 | |
| GeneOntologyBiologicalProcess | D-amino acid transport | 6.02e-04 | 8 | 97 | 2 | GO:0042940 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | CACNA1B SCN11A CNNM2 ANXA6 SLC13A3 TLR9 SLC1A1 SLC1A3 SLC5A2 SLC5A4 JPH1 SLC5A11 LRRC55 CNNM4 SLC10A5 CACNA1H | 6.46e-04 | 1374 | 97 | 16 | GO:0006811 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | CACNA1B SCN11A CNNM2 ANXA6 SLC13A3 TLR9 SLC1A1 SLC1A3 SLC5A2 SLC5A4 JPH1 LRRC55 CNNM4 CACNA1H | 7.04e-04 | 1115 | 97 | 14 | GO:0034220 |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte mediated immunity | 7.16e-04 | 150 | 97 | 5 | GO:0002708 | |
| GeneOntologyBiologicalProcess | positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 7.16e-04 | 150 | 97 | 5 | GO:0002824 | |
| GeneOntologyBiologicalProcess | transepithelial transport | 7.55e-04 | 38 | 97 | 3 | GO:0070633 | |
| GeneOntologyBiologicalProcess | transport across blood-brain barrier | 7.59e-04 | 87 | 97 | 4 | GO:0150104 | |
| GeneOntologyBiologicalProcess | vascular transport | 7.92e-04 | 88 | 97 | 4 | GO:0010232 | |
| GeneOntologyBiologicalProcess | positive regulation of cell killing | 7.92e-04 | 88 | 97 | 4 | GO:0031343 | |
| GeneOntologyBiologicalProcess | positive regulation of adaptive immune response | 9.31e-04 | 159 | 97 | 5 | GO:0002821 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | CACNA1B SCN11A CNNM2 SLC13A3 TLR9 SLC1A1 SLC1A3 SLC5A2 SLC5A4 JPH1 LRRC55 CNNM4 CACNA1H | 9.40e-04 | 1017 | 97 | 13 | GO:0098660 |
| GeneOntologyBiologicalProcess | cellular response to cocaine | 9.61e-04 | 10 | 97 | 2 | GO:0071314 | |
| GeneOntologyCellularComponent | immunoglobulin complex | IGKV1-39 IGKV1-37 IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-13 IGKV1-12 IGKV1-9 IGKV1-6 IGKV1-5 IGKV2D-30 IGKV2D-29 IGKV2D-28 IGKV2D-26 IGKV1D-43 IGKV1D-42 IGKV1D-39 IGKV1D-37 IGKV1D-33 IGKV1D-17 IGKV1D-13 IGKV1D-12 IGKV1D-8 IGKV2-40 IGKV2-30 IGKV2-29 IGKV2-28 | 3.49e-34 | 166 | 101 | 27 | GO:0019814 |
| GeneOntologyCellularComponent | MHC class I protein complex | 1.05e-07 | 10 | 101 | 4 | GO:0042612 | |
| GeneOntologyCellularComponent | blood microparticle | IGKV1-39 IGKV1-17 SERPINA3 IGKV1-5 IGKV2D-28 IGKV1D-33 IGKV1D-12 IGKV2-30 | 4.91e-07 | 144 | 101 | 8 | GO:0072562 |
| GeneOntologyCellularComponent | MHC class Ib protein complex | 3.78e-06 | 7 | 101 | 3 | GO:0032398 | |
| GeneOntologyCellularComponent | MHC protein complex | 7.07e-06 | 26 | 101 | 4 | GO:0042611 | |
| GeneOntologyCellularComponent | MHC class I peptide loading complex | 3.83e-05 | 14 | 101 | 3 | GO:0042824 | |
| GeneOntologyCellularComponent | endoplasmic reticulum exit site | 4.99e-05 | 42 | 101 | 4 | GO:0070971 | |
| GeneOntologyCellularComponent | cis-Golgi network membrane | 7.09e-05 | 17 | 101 | 3 | GO:0033106 | |
| GeneOntologyCellularComponent | Golgi medial cisterna | 1.81e-04 | 23 | 101 | 3 | GO:0005797 | |
| GeneOntologyCellularComponent | membrane raft | 3.73e-04 | 362 | 101 | 8 | GO:0045121 | |
| GeneOntologyCellularComponent | membrane microdomain | 3.87e-04 | 364 | 101 | 8 | GO:0098857 | |
| GeneOntologyCellularComponent | Golgi cisterna | 5.03e-04 | 135 | 101 | 5 | GO:0031985 | |
| GeneOntologyCellularComponent | early endosome membrane | 5.77e-04 | 212 | 101 | 6 | GO:0031901 | |
| GeneOntologyCellularComponent | lumenal side of endoplasmic reticulum membrane | 6.40e-04 | 35 | 101 | 3 | GO:0098553 | |
| GeneOntologyCellularComponent | cell surface | HLA-A HLA-C TMEM8B AZGP1 HLA-H MR1 DUOX2 DCSTAMP ACVRL1 SLC1A1 SLC1A3 SLC2A4 CUZD1 CA4 | 8.99e-04 | 1111 | 101 | 14 | GO:0009986 |
| GeneOntologyCellularComponent | phagocytic vesicle | 9.95e-04 | 157 | 101 | 5 | GO:0045335 | |
| GeneOntologyCellularComponent | Golgi apparatus subcompartment | 1.38e-03 | 443 | 101 | 8 | GO:0098791 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | CACNA1B TRAV8-1 SCN11A HLA-A HLA-C HLA-H MR1 DUOX2 ACVRL1 LRRC55 CACNA1H | 1.44e-03 | 785 | 101 | 11 | GO:0098797 |
| GeneOntologyCellularComponent | Golgi stack | 1.45e-03 | 171 | 101 | 5 | GO:0005795 | |
| GeneOntologyCellularComponent | lumenal side of membrane | 1.62e-03 | 48 | 101 | 3 | GO:0098576 | |
| GeneOntologyCellularComponent | recycling endosome membrane | 2.14e-03 | 112 | 101 | 4 | GO:0055038 | |
| GeneOntologyCellularComponent | apical plasma membrane | 2.50e-03 | 487 | 101 | 8 | GO:0016324 | |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 3.00e-03 | 17 | 101 | 2 | GO:0001518 | |
| GeneOntologyCellularComponent | endoplasmic reticulum protein-containing complex | 3.18e-03 | 125 | 101 | 4 | GO:0140534 | |
| GeneOntologyCellularComponent | ER to Golgi transport vesicle membrane | 3.68e-03 | 64 | 101 | 3 | GO:0012507 | |
| GeneOntologyCellularComponent | coated vesicle membrane | 3.91e-03 | 215 | 101 | 5 | GO:0030662 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | EREG HLA-A COPB1 HLA-C ANXA6 LRRK2 HLA-H MR1 TLR9 DCSTAMP SLC1A1 SLC2A4 CUZD1 CA4 | 4.05e-03 | 1307 | 101 | 14 | GO:0030659 |
| GeneOntologyCellularComponent | recycling endosome | 4.48e-03 | 222 | 101 | 5 | GO:0055037 | |
| GeneOntologyCellularComponent | vesicle membrane | EREG HLA-A COPB1 HLA-C ANXA6 LRRK2 HLA-H MR1 TLR9 DCSTAMP SLC1A1 SLC2A4 CUZD1 CA4 | 4.57e-03 | 1325 | 101 | 14 | GO:0012506 |
| GeneOntologyCellularComponent | basolateral plasma membrane | 4.61e-03 | 320 | 101 | 6 | GO:0016323 | |
| MousePheno | spinal cord inflammation | 4.15e-06 | 8 | 60 | 3 | MP:0030987 | |
| MousePheno | decreased susceptibility to autoimmune diabetes | 4.01e-05 | 45 | 60 | 4 | MP:0004804 | |
| MousePheno | abnormal susceptibility to autoimmune disorder | 4.68e-05 | 307 | 60 | 8 | MP:0002425 | |
| Domain | MHC_I | 1.65e-08 | 21 | 74 | 5 | PF00129 | |
| Domain | MHC_I_a_a1/a2 | 1.65e-08 | 21 | 74 | 5 | IPR001039 | |
| Domain | MHC_I_a_C | 1.18e-06 | 6 | 74 | 3 | IPR010579 | |
| Domain | MHC_I_C | 1.18e-06 | 6 | 74 | 3 | PF06623 | |
| Domain | - | 2.27e-06 | 24 | 74 | 4 | 3.30.500.10 | |
| Domain | MHC_I-like_Ag-recog | 2.27e-06 | 24 | 74 | 4 | IPR011161 | |
| Domain | C1-set | 2.31e-06 | 54 | 74 | 5 | PF07654 | |
| Domain | IGc1 | 2.78e-06 | 56 | 74 | 5 | SM00407 | |
| Domain | Ig_C1-set | 3.31e-06 | 58 | 74 | 5 | IPR003597 | |
| Domain | Ig/MHC_CS | 3.31e-06 | 58 | 74 | 5 | IPR003006 | |
| Domain | IG_MHC | 3.92e-06 | 60 | 74 | 5 | PS00290 | |
| Domain | NA_SOLUT_SYMP_1 | 9.63e-06 | 11 | 74 | 3 | PS00456 | |
| Domain | NA_SOLUT_SYMP_2 | 1.28e-05 | 12 | 74 | 3 | PS00457 | |
| Domain | SSF | 1.28e-05 | 12 | 74 | 3 | PF00474 | |
| Domain | Na/solute_symporter | 1.28e-05 | 12 | 74 | 3 | IPR001734 | |
| Domain | NA_SOLUT_SYMP_3 | 1.28e-05 | 12 | 74 | 3 | PS50283 | |
| Domain | MHC_I/II-like_Ag-recog | 1.51e-05 | 38 | 74 | 4 | IPR011162 | |
| Domain | DUF21 | 9.24e-05 | 4 | 74 | 2 | IPR002550 | |
| Domain | DUF21 | 9.24e-05 | 4 | 74 | 2 | PF01595 | |
| Domain | Na-dicarboxylate_symporter | 3.21e-04 | 7 | 74 | 2 | IPR001991 | |
| Domain | NA_DICARBOXYL_SYMP_1 | 3.21e-04 | 7 | 74 | 2 | PS00713 | |
| Domain | NA_DICARBOXYL_SYMP_2 | 3.21e-04 | 7 | 74 | 2 | PS00714 | |
| Domain | Na-dicarboxylate_symporter_CS | 3.21e-04 | 7 | 74 | 2 | IPR018107 | |
| Domain | SDF | 3.21e-04 | 7 | 74 | 2 | PF00375 | |
| Domain | - | 3.21e-04 | 7 | 74 | 2 | 1.10.3860.10 | |
| Domain | Na/solute_symporter_CS | 4.27e-04 | 8 | 74 | 2 | IPR018212 | |
| Domain | Haem_peroxidase | 6.83e-04 | 10 | 74 | 2 | IPR010255 | |
| Domain | An_peroxidase | 6.83e-04 | 10 | 74 | 2 | PF03098 | |
| Domain | PEROXIDASE_3 | 6.83e-04 | 10 | 74 | 2 | PS50292 | |
| Domain | Haem_peroxidase_animal | 6.83e-04 | 10 | 74 | 2 | IPR019791 | |
| Domain | VDCCAlpha1 | 6.83e-04 | 10 | 74 | 2 | IPR002077 | |
| Domain | - | 6.83e-04 | 10 | 74 | 2 | 1.10.640.10 | |
| Domain | LRR | 1.21e-03 | 201 | 74 | 5 | PS51450 | |
| Domain | Channel_four-helix_dom | 1.50e-03 | 57 | 74 | 3 | IPR027359 | |
| Domain | - | 1.50e-03 | 57 | 74 | 3 | 1.20.120.350 | |
| Domain | - | 1.88e-03 | 222 | 74 | 5 | 1.25.10.10 | |
| Domain | ARM-type_fold | 2.25e-03 | 339 | 74 | 6 | IPR016024 | |
| Domain | CBS_dom | 2.81e-03 | 20 | 74 | 2 | IPR000644 | |
| Domain | CBS | 2.81e-03 | 20 | 74 | 2 | PF00571 | |
| Domain | CBS | 2.81e-03 | 20 | 74 | 2 | PS51371 | |
| Domain | IG_LIKE | 3.28e-03 | 491 | 74 | 7 | PS50835 | |
| Domain | Claudin_CS | 3.40e-03 | 22 | 74 | 2 | IPR017974 | |
| Domain | CLAUDIN | 3.40e-03 | 22 | 74 | 2 | PS01346 | |
| Domain | Quino_amine_DH_bsu | 3.40e-03 | 22 | 74 | 2 | IPR011044 | |
| Domain | Ig-like_dom | 3.74e-03 | 503 | 74 | 7 | IPR007110 | |
| Domain | ARM-like | 4.35e-03 | 270 | 74 | 5 | IPR011989 | |
| Domain | Leu-rich_rpt | 4.42e-03 | 271 | 74 | 5 | IPR001611 | |
| Domain | LRR_8 | 4.74e-03 | 171 | 74 | 4 | PF13855 | |
| Domain | Leu-rich_rpt_typical-subtyp | 5.36e-03 | 177 | 74 | 4 | IPR003591 | |
| Domain | LRR_TYP | 5.36e-03 | 177 | 74 | 4 | SM00369 | |
| Domain | Claudin | 5.48e-03 | 28 | 74 | 2 | IPR006187 | |
| Domain | Ig-like_fold | 6.71e-03 | 706 | 74 | 8 | IPR013783 | |
| Pathway | REACTOME_CD22_MEDIATED_BCR_REGULATION | IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-5 IGKV2D-40 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12 IGKV2-30 IGKV2-28 | 6.55e-22 | 61 | 73 | 15 | M27581 |
| Pathway | REACTOME_FCERI_MEDIATED_CA_2_MOBILIZATION | IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-5 LAT IGKV2D-40 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12 IGKV2-30 IGKV2-28 | 3.38e-21 | 86 | 73 | 16 | M27206 |
| Pathway | REACTOME_FCERI_MEDIATED_MAPK_ACTIVATION | IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-5 LAT IGKV2D-40 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12 IGKV2-30 IGKV2-28 | 4.13e-21 | 87 | 73 | 16 | M27205 |
| Pathway | REACTOME_FCGR_ACTIVATION | IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-5 IGKV2D-40 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12 IGKV2-30 IGKV2-28 | 5.11e-21 | 69 | 73 | 15 | M27108 |
| Pathway | REACTOME_SCAVENGING_OF_HEME_FROM_PLASMA | IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-5 IGKV2D-40 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12 IGKV2-30 IGKV2-28 | 5.11e-21 | 69 | 73 | 15 | M27150 |
| Pathway | REACTOME_CREATION_OF_C4_AND_C2_ACTIVATORS | IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-5 IGKV2D-40 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12 IGKV2-30 IGKV2-28 | 8.18e-21 | 71 | 73 | 15 | M1078 |
| Pathway | REACTOME_ROLE_OF_LAT2_NTAL_LAB_ON_CALCIUM_MOBILIZATION | IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-5 IGKV2D-40 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12 IGKV2-30 IGKV2-28 | 8.18e-21 | 71 | 73 | 15 | M27203 |
| Pathway | REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT | IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-5 IGKV2D-40 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12 IGKV2-30 IGKV2-28 | 5.73e-20 | 80 | 73 | 15 | M6121 |
| Pathway | REACTOME_ROLE_OF_PHOSPHOLIPIDS_IN_PHAGOCYTOSIS | IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-5 IGKV2D-40 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12 IGKV2-30 IGKV2-28 | 8.54e-20 | 82 | 73 | 15 | M27110 |
| Pathway | REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_BCR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS | IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-5 IGKV2D-40 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12 IGKV2-30 IGKV2-28 | 1.84e-19 | 86 | 73 | 15 | M601 |
| Pathway | REACTOME_FCGR3A_MEDIATED_IL10_SYNTHESIS | IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-5 IGKV2D-40 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12 IGKV2-30 IGKV2-28 | 8.99e-19 | 95 | 73 | 15 | M29842 |
| Pathway | REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS | IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-5 IGKV2D-40 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12 IGKV2-30 IGKV2-28 | 1.47e-18 | 98 | 73 | 15 | M27152 |
| Pathway | REACTOME_COMPLEMENT_CASCADE | IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-5 IGKV2D-40 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12 IGKV2-30 IGKV2-28 | 1.81e-17 | 115 | 73 | 15 | M19752 |
| Pathway | REACTOME_PARASITE_INFECTION | IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-5 IGKV2D-40 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12 IGKV2-30 IGKV2-28 | 2.07e-17 | 116 | 73 | 15 | M29843 |
| Pathway | REACTOME_POTENTIAL_THERAPEUTICS_FOR_SARS | IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-12 TLR9 IGKV1-5 IGKV2D-40 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12 IGKV2-30 IGKV2-28 | 5.75e-17 | 154 | 73 | 16 | M39007 |
| Pathway | REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL | IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-12 HLA-A HLA-C IGKV1-5 IGKV2D-40 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12 IGKV2-30 IGKV2-28 | 7.09e-17 | 190 | 73 | 17 | M8240 |
| Pathway | REACTOME_ANTI_INFLAMMATORY_RESPONSE_FAVOURING_LEISHMANIA_PARASITE_INFECTION | IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-5 IGKV2D-40 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12 IGKV2-30 IGKV2-28 | 1.91e-16 | 134 | 73 | 15 | M29840 |
| Pathway | REACTOME_FCERI_MEDIATED_NF_KB_ACTIVATION | IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-5 IGKV2D-40 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12 IGKV2-30 IGKV2-28 | 2.40e-16 | 136 | 73 | 15 | M27207 |
| Pathway | REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS | IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-5 IGKV2D-40 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12 IGKV2-30 IGKV2-28 | 5.16e-16 | 143 | 73 | 15 | M27107 |
| Pathway | REACTOME_FC_EPSILON_RECEPTOR_FCERI_SIGNALING | IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-5 LAT IGKV2D-40 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12 IGKV2-30 IGKV2-28 | 1.20e-15 | 186 | 73 | 16 | M27175 |
| Pathway | REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR | IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-5 IGKV2D-40 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12 IGKV2-30 IGKV2-28 | 4.93e-15 | 166 | 73 | 15 | M608 |
| Pathway | REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL | IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-5 IGKV2D-40 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12 IGKV2-30 IGKV2-28 | 5.04e-14 | 194 | 73 | 15 | M16312 |
| Pathway | REACTOME_LEISHMANIA_INFECTION | IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-5 IGKV2D-40 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12 IGKV2-30 IGKV2-28 | 3.01e-13 | 219 | 73 | 15 | M29836 |
| Pathway | REACTOME_SARS_COV_INFECTIONS | IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-12 HLA-A HLA-C TLR9 IGKV1-5 IGKV2D-40 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12 IGKV2-30 IGKV2-28 | 1.96e-11 | 471 | 73 | 18 | M39009 |
| Pathway | REACTOME_VESICLE_MEDIATED_TRANSPORT | IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-12 EREG COPB1 TMEM115 SLC2A4 IGKV1-5 IGKV2D-40 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12 IGKV2-30 IGKV2-28 | 2.98e-09 | 725 | 73 | 19 | M27507 |
| Pathway | REACTOME_ADAPTIVE_IMMUNE_SYSTEM | IGKV1-39 CUL2 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-12 HLA-A HLA-C IGKV1-5 LAT IGKV2D-40 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12 IGKV2-30 IGKV2-28 | 2.59e-08 | 828 | 73 | 19 | M1058 |
| Pathway | REACTOME_HEMOSTASIS | IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 SERPINA3 IGKV1-12 IGKV1-5 LAT IGKV2D-40 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12 IGKV2-30 IGKV2-28 | 4.66e-08 | 679 | 73 | 17 | M8395 |
| Pathway | REACTOME_INNATE_IMMUNE_SYSTEM | MPO IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 SERPINA3 IGKV1-12 COPB1 HLA-C TLR9 IGKV1-5 LAT IGKV2D-40 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12 IGKV2-30 IGKV2-28 | 1.48e-07 | 1128 | 73 | 21 | M1036 |
| Pathway | REACTOME_VIRAL_INFECTION_PATHWAYS | IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-12 HLA-A HLA-C TLR9 IGKV1-5 IGKV2D-40 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12 IGKV2-30 IGKV2-28 | 4.18e-07 | 888 | 73 | 18 | M48034 |
| Pathway | REACTOME_INFECTIOUS_DISEASE | IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-12 HLA-A HLA-C TLR9 IGKV1-5 IGKV2D-40 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12 IGKV2-30 IGKV2-28 | 6.98e-06 | 1081 | 73 | 18 | M27548 |
| Pathway | BIOCARTA_NKCELLS_PATHWAY | 7.71e-06 | 25 | 73 | 4 | MM1465 | |
| Pathway | REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY | 1.09e-05 | 9 | 73 | 3 | MM14527 | |
| Pathway | REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL | 6.94e-05 | 135 | 73 | 6 | MM14781 | |
| Pathway | REACTOME_ER_PHAGOSOME_PATHWAY | 1.03e-04 | 18 | 73 | 3 | MM14525 | |
| Pathway | REACTOME_CELLULAR_HEXOSE_TRANSPORT | 1.22e-04 | 19 | 73 | 3 | MM14718 | |
| Pathway | BIOCARTA_CTL_PATHWAY | 1.43e-04 | 20 | 73 | 3 | MM1374 | |
| Pathway | REACTOME_CELLULAR_HEXOSE_TRANSPORT | 1.66e-04 | 21 | 73 | 3 | M27058 | |
| Pathway | REACTOME_DAP12_INTERACTIONS | 1.72e-04 | 54 | 73 | 4 | MM14871 | |
| Pathway | WP_PROXIMAL_TUBULE_TRANSPORT | 2.12e-04 | 57 | 73 | 4 | M39812 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 2.26e-04 | 238 | 73 | 7 | MM15076 | |
| Pathway | REACTOME_FCERI_MEDIATED_CA_2_MOBILIZATION | 2.27e-04 | 58 | 73 | 4 | MM14914 | |
| Pathway | REACTOME_FCERI_MEDIATED_MAPK_ACTIVATION | 2.59e-04 | 60 | 73 | 4 | MM14913 | |
| Pathway | REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC | 2.82e-04 | 25 | 73 | 3 | MM15713 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 2.98e-04 | 249 | 73 | 7 | M5988 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_KSHV_MIR1_2_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 3.91e-04 | 6 | 73 | 2 | M47468 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HTLV_1_P12_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 5.46e-04 | 7 | 73 | 2 | M47582 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E5_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 5.46e-04 | 7 | 73 | 2 | M47530 | |
| Pathway | REACTOME_CD22_MEDIATED_BCR_REGULATION | 7.74e-04 | 35 | 73 | 3 | MM17219 | |
| Pathway | REACTOME_CLASSICAL_ANTIBODY_MEDIATED_COMPLEMENT_ACTIVATION | 1.07e-03 | 39 | 73 | 3 | MM17212 | |
| Pathway | REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY | 1.41e-03 | 11 | 73 | 2 | M525 | |
| Pathway | REACTOME_ROLE_OF_LAT2_NTAL_LAB_ON_CALCIUM_MOBILIZATION | 1.62e-03 | 45 | 73 | 3 | MM14912 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 1.69e-03 | 12 | 73 | 2 | M47529 | |
| Pathway | REACTOME_FCGR_ACTIVATION | 1.95e-03 | 48 | 73 | 3 | MM17214 | |
| Pathway | REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_BCR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS | 2.59e-03 | 53 | 73 | 3 | MM15716 | |
| Pathway | REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT | 2.73e-03 | 54 | 73 | 3 | MM14655 | |
| Pathway | REACTOME_ROLE_OF_PHOSPHOLIPIDS_IN_PHAGOCYTOSIS | 3.03e-03 | 56 | 73 | 3 | MM14815 | |
| Pathway | REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS | 3.69e-03 | 60 | 73 | 3 | MM14872 | |
| Pubmed | IGKV1-39 IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-13 IGKV1-9 IGKV1-6 IGKV1-5 IGKV2D-28 IGKV1D-43 IGKV1D-39 IGKV1D-33 IGKV1D-17 IGKV1D-13 IGKV1D-8 IGKV2-28 | 5.84e-38 | 20 | 104 | 16 | 10427970 | |
| Pubmed | MPO IGKV1-39 IGKV1-27 IGKV1-13 IGKV1-12 IGKV1-9 IGKV1-5 IGKV2D-28 IGKV1D-43 IGKV1D-39 IGKV1D-33 IGKV1D-13 IGKV1D-12 IGKV1D-8 IGKV2-28 | 3.85e-36 | 18 | 104 | 15 | 20399194 | |
| Pubmed | IGKV2D-40 IGKV2D-30 IGKV2D-29 IGKV2D-28 IGKV2D-26 IGKV1D-43 IGKV1D-42 IGKV1D-39 IGKV1D-37 IGKV1D-33 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 IGKV1D-8 | 2.51e-29 | 36 | 104 | 15 | 11298326 | |
| Pubmed | IGKV1-39 IGKV1-27 IGKV1-13 IGKV1-9 IGKV1-5 IGKV1D-43 IGKV1D-39 IGKV1D-33 IGKV1D-13 IGKV1D-8 | 4.02e-25 | 11 | 104 | 10 | 6795447 | |
| Pubmed | Multiple related immunoglobulin variable-region genes identified by cloning and sequence analysis. | IGKV1-39 IGKV1-27 IGKV1-13 IGKV1-9 IGKV1-5 IGKV1D-43 IGKV1D-39 IGKV1D-33 IGKV1D-13 IGKV1D-8 | 4.02e-25 | 11 | 104 | 10 | 279004 |
| Pubmed | Organization and complete sequence of identical embryonic and plasmacytoma kappa V-region genes. | IGKV1-39 IGKV1-27 IGKV1-13 IGKV1-9 IGKV1-5 IGKV1D-43 IGKV1D-39 IGKV1D-33 IGKV1D-13 IGKV1D-8 | 4.02e-25 | 11 | 104 | 10 | 6767723 |
| Pubmed | IGKV1-39 IGKV1-17 IGKV1-16 IGKV1-13 IGKV1-6 IGKV1-5 IGKV1D-39 IGKV1D-17 IGKV1D-13 | 1.34e-23 | 9 | 104 | 9 | 6777049 | |
| Pubmed | IGKV1-39 IGKV1-17 IGKV1-16 IGKV1-13 IGKV1-6 IGKV1-5 IGKV1D-39 IGKV1D-17 IGKV1D-13 | 1.51e-19 | 16 | 104 | 9 | 17124007 | |
| Pubmed | IGKV1-17 IGKV1-12 IGKV1D-43 IGKV1D-42 IGKV1D-17 IGKV1D-13 IGKV1D-12 | 3.30e-14 | 17 | 104 | 7 | 8223863 | |
| Pubmed | IMGT/GENE-DB: a comprehensive database for human and mouse immunoglobulin and T cell receptor genes. | IGKV1-39 IGKV1-17 IGKV1-16 IGKV1-13 IGKV1-6 IGKV1-5 IGKV1D-39 IGKV1D-33 IGKV1D-17 IGKV1D-13 | 3.41e-14 | 77 | 104 | 10 | 15608191 |
| Pubmed | The human immunoglobulin kappa locus. Characterization of the duplicated A regions. | 1.28e-13 | 10 | 104 | 6 | 1551402 | |
| Pubmed | The human immunoglobulin kappa locus. Characterization of the duplicated O regions. | 2.17e-13 | 5 | 104 | 5 | 1907917 | |
| Pubmed | IGKV1-39 IGKV1-17 SERPINA3 IGKV1-5 IGKV2D-28 IGKV1D-33 IGKV1D-12 IGKV2-40 IGKV2-30 | 5.14e-10 | 143 | 104 | 9 | 22516433 | |
| Pubmed | IGKV2D-30 IGKV2D-29 IGKV2D-26 IGKV2-40 IGKV2-30 IGKV2-29 IGKV2-28 | 2.93e-09 | 75 | 104 | 7 | 31527668 | |
| Pubmed | 2.45e-08 | 11 | 104 | 4 | 20466823 | ||
| Pubmed | 2.60e-08 | 3 | 104 | 3 | 1940382 | ||
| Pubmed | 2.59e-07 | 5 | 104 | 3 | 6086934 | ||
| Pubmed | IGKV1-39 IGKV1-33 IGKV1-17 SERPINA3 HLA-A AZGP1 IGKV1-5 RIF1 RUVBL1 IGKV1D-33 IGKV1D-12 IGKV2-30 | 6.13e-07 | 652 | 104 | 12 | 31180492 | |
| Pubmed | 9.01e-07 | 7 | 104 | 3 | 1705528 | ||
| Pubmed | 9.01e-07 | 7 | 104 | 3 | 2808323 | ||
| Pubmed | 9.01e-07 | 7 | 104 | 3 | 21088134 | ||
| Pubmed | 9.01e-07 | 7 | 104 | 3 | 69663 | ||
| Pubmed | Direct link between mhc polymorphism, T cell avidity, and diversity in immune defense. | 9.01e-07 | 7 | 104 | 3 | 12459592 | |
| Pubmed | Multiple sequences related to classical histocompatibility antigens in the mouse genome. | 9.01e-07 | 7 | 104 | 3 | 6264319 | |
| Pubmed | Sequence analysis of the C3H H-2K1k gene: relationship to the H-2 loci. | 9.01e-07 | 7 | 104 | 3 | 2714856 | |
| Pubmed | 9.01e-07 | 7 | 104 | 3 | 10500200 | ||
| Pubmed | Structural analysis of H-2Kf and H-2Kfm1 by using H-2K locus-specific sequences. | 9.01e-07 | 7 | 104 | 3 | 2391419 | |
| Pubmed | 9.01e-07 | 7 | 104 | 3 | 15671142 | ||
| Pubmed | 9.01e-07 | 7 | 104 | 3 | 14215561 | ||
| Pubmed | A saturation hypothesis to explain both enhanced and impaired learning with enhanced plasticity. | 9.01e-07 | 7 | 104 | 3 | 28234229 | |
| Pubmed | Interaction of H-2Db with mutant histocompatibility gene H (KH-11) in the mouse. | 9.01e-07 | 7 | 104 | 3 | 6242891 | |
| Pubmed | 9.01e-07 | 7 | 104 | 3 | 17512611 | ||
| Pubmed | 9.01e-07 | 7 | 104 | 3 | 7018573 | ||
| Pubmed | 9.01e-07 | 7 | 104 | 3 | 2642506 | ||
| Pubmed | 9.01e-07 | 7 | 104 | 3 | 9037062 | ||
| Pubmed | 9.01e-07 | 7 | 104 | 3 | 1840571 | ||
| Pubmed | 9.01e-07 | 7 | 104 | 3 | 20957233 | ||
| Pubmed | 9.01e-07 | 7 | 104 | 3 | 11580250 | ||
| Pubmed | V beta T cell repertoire of CD8+ splenocytes selected on nonpolymorphic MHC class I molecules. | 9.01e-07 | 7 | 104 | 3 | 11086076 | |
| Pubmed | 9.01e-07 | 7 | 104 | 3 | 12750360 | ||
| Pubmed | 9.01e-07 | 7 | 104 | 3 | 18416856 | ||
| Pubmed | Convergent recombination shapes the clonotypic landscape of the naive T-cell repertoire. | 9.01e-07 | 7 | 104 | 3 | 20974936 | |
| Pubmed | 9.01e-07 | 7 | 104 | 3 | 10704462 | ||
| Pubmed | 9.01e-07 | 7 | 104 | 3 | 22573867 | ||
| Pubmed | A novel H-2K splice form: predictions for other alternative H-2 splicing events. | 9.01e-07 | 7 | 104 | 3 | 2908875 | |
| Pubmed | Comparison of exon 5 sequences from 35 class I genes of the BALB/c mouse. | 9.01e-07 | 7 | 104 | 3 | 2584927 | |
| Pubmed | 9.01e-07 | 7 | 104 | 3 | 3496275 | ||
| Pubmed | 9.01e-07 | 7 | 104 | 3 | 12147629 | ||
| Pubmed | 9.01e-07 | 7 | 104 | 3 | 3458188 | ||
| Pubmed | 9.01e-07 | 7 | 104 | 3 | 19462379 | ||
| Pubmed | Structural diversity of the classical H-2 genes: K, D, and L. | 9.01e-07 | 7 | 104 | 3 | 1730883 | |
| Pubmed | 9.01e-07 | 7 | 104 | 3 | 3680952 | ||
| Pubmed | Thymus leukemia antigen controls intraepithelial lymphocyte function and inflammatory bowel disease. | 9.01e-07 | 7 | 104 | 3 | 19004778 | |
| Pubmed | 9.01e-07 | 7 | 104 | 3 | 6300887 | ||
| Pubmed | H-2-linked regulation of xenotropic murine leukemia virus expression. | 9.01e-07 | 7 | 104 | 3 | 6300850 | |
| Pubmed | 9.01e-07 | 7 | 104 | 3 | 8500526 | ||
| Pubmed | cDNA clone coding for part of a mouse H-2d major histocompatibility antigen. | 9.01e-07 | 7 | 104 | 3 | 6265910 | |
| Pubmed | Cutting edge: MHC class I-Ly49 interaction regulates neuronal function. | 9.01e-07 | 7 | 104 | 3 | 18453559 | |
| Pubmed | DNA polymorphisms defined by the Tu108 probe map to the Tla region of mouse chromosome 17. | 9.01e-07 | 7 | 104 | 3 | 2906539 | |
| Pubmed | 9.01e-07 | 7 | 104 | 3 | 3013627 | ||
| Pubmed | DNA sequence of the mouse H-2Dd transplantation antigen gene. | 9.01e-07 | 7 | 104 | 3 | 3856254 | |
| Pubmed | 9.01e-07 | 7 | 104 | 3 | 3894562 | ||
| Pubmed | 9.01e-07 | 7 | 104 | 3 | 27385590 | ||
| Pubmed | 9.01e-07 | 7 | 104 | 3 | 1348042 | ||
| Pubmed | H2-K(b) and H2-D(b) regulate cerebellar long-term depression and limit motor learning. | 9.01e-07 | 7 | 104 | 3 | 19346486 | |
| Pubmed | Liver sinusoidal endothelial cells veto CD8 T cell activation by antigen-presenting dendritic cells. | 9.01e-07 | 7 | 104 | 3 | 18383043 | |
| Pubmed | 9.01e-07 | 7 | 104 | 3 | 16272298 | ||
| Pubmed | Tissue-specific expression of an unusual H-2 (class I)-related gene. | 9.01e-07 | 7 | 104 | 3 | 6956903 | |
| Pubmed | 9.01e-07 | 7 | 104 | 3 | 8833240 | ||
| Pubmed | 9.01e-07 | 7 | 104 | 3 | 21178009 | ||
| Pubmed | Expression and function of transplantation antigens with altered or deleted cytoplasmic domains. | 9.01e-07 | 7 | 104 | 3 | 6604582 | |
| Pubmed | Isolation of a cDNA clone for the murine transplantation antigen H-2Kb. | 9.01e-07 | 7 | 104 | 3 | 6954478 | |
| Pubmed | 9.01e-07 | 7 | 104 | 3 | 34525366 | ||
| Pubmed | 9.01e-07 | 7 | 104 | 3 | 3374494 | ||
| Pubmed | Extensive deletions in the Q region of the mouse major histocompatibility complex. | 9.01e-07 | 7 | 104 | 3 | 3025084 | |
| Pubmed | 9.01e-07 | 7 | 104 | 3 | 2543831 | ||
| Pubmed | 9.01e-07 | 7 | 104 | 3 | 2989712 | ||
| Pubmed | Unique biochemical properties of a mutant MHC class I molecule, H-2Ksm1. | 9.01e-07 | 7 | 104 | 3 | 1280760 | |
| Pubmed | Three cDNA clones encoding mouse transplantation antigens: homology to immunoglobulin genes. | 9.01e-07 | 7 | 104 | 3 | 6786753 | |
| Pubmed | 9.01e-07 | 7 | 104 | 3 | 6583704 | ||
| Pubmed | 9.01e-07 | 7 | 104 | 3 | 6571712 | ||
| Pubmed | 9.01e-07 | 7 | 104 | 3 | 9222352 | ||
| Pubmed | 9.01e-07 | 7 | 104 | 3 | 12006653 | ||
| Pubmed | 9.01e-07 | 7 | 104 | 3 | 1699529 | ||
| Pubmed | 9.01e-07 | 7 | 104 | 3 | 17982076 | ||
| Pubmed | 9.01e-07 | 7 | 104 | 3 | 7520098 | ||
| Pubmed | 9.01e-07 | 7 | 104 | 3 | 15644207 | ||
| Pubmed | How a single T cell receptor recognizes both self and foreign MHC. | 9.01e-07 | 7 | 104 | 3 | 17418792 | |
| Pubmed | 9.01e-07 | 7 | 104 | 3 | 9185075 | ||
| Pubmed | 9.01e-07 | 7 | 104 | 3 | 21483793 | ||
| Pubmed | 9.01e-07 | 7 | 104 | 3 | 10452993 | ||
| Pubmed | Intestinal epithelial cells modulate CD4 T cell responses via the thymus leukemia antigen. | 9.01e-07 | 7 | 104 | 3 | 21900182 | |
| Pubmed | 9.01e-07 | 7 | 104 | 3 | 15272181 | ||
| Pubmed | Genetic control of scrapie and Creutzfeldt-Jakob disease in mice. | 9.01e-07 | 7 | 104 | 3 | 6408182 | |
| Pubmed | 9.01e-07 | 7 | 104 | 3 | 26714929 | ||
| Pubmed | Partial nucleotide sequence of H-2Dd major histocompatibility antigen gene. | 9.01e-07 | 7 | 104 | 3 | 3925012 | |
| Pubmed | 9.01e-07 | 7 | 104 | 3 | 6280871 | ||
| Pubmed | 9.01e-07 | 7 | 104 | 3 | 10799615 | ||
| Pubmed | 9.01e-07 | 7 | 104 | 3 | 10993729 | ||
| Pubmed | 9.01e-07 | 7 | 104 | 3 | 1339405 | ||
| Interaction | HLA-B interactions | 1.27e-05 | 239 | 91 | 8 | int:HLA-B | |
| Interaction | HLA-G interactions | 1.58e-05 | 118 | 91 | 6 | int:HLA-G | |
| Cytoband | 2p12 | IGKV1-39 IGKV1-37 IGKV1-33 IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-13 IGKV1-12 IGKV1-9 IGKV1-6 IGKV1-5 IGKV2D-40 IGKV2D-30 IGKV2D-29 IGKV2D-28 IGKV2D-26 IGKV1D-43 IGKV1D-42 IGKV1D-39 IGKV1D-37 IGKV1D-33 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 IGKV1D-8 IGKV2-40 IGKV2-30 IGKV2-29 IGKV2-28 | 2.71e-54 | 117 | 104 | 30 | 2p12 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2p11 | IGKV1-39 IGKV1-37 IGKV1-33 IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-13 IGKV1-12 IGKV1-9 IGKV1-6 IGKV1-5 IGKV2D-40 IGKV2D-30 IGKV2D-29 IGKV2D-28 IGKV2D-26 IGKV1D-43 IGKV1D-42 IGKV1D-39 IGKV1D-37 IGKV1D-33 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 IGKV1D-8 IGKV2-40 IGKV2-30 IGKV2-29 IGKV2-28 | 1.03e-45 | 213 | 104 | 30 | chr2p11 |
| Cytoband | 3p21.3 | 3.35e-04 | 59 | 104 | 3 | 3p21.3 | |
| GeneFamily | Immunoglobulin kappa locus at 2p11.2 | IGKV1-39 IGKV1-37 IGKV1-33 IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-13 IGKV1-12 IGKV1-9 IGKV1-6 IGKV1-5 IGKV2D-40 IGKV2D-30 IGKV2D-29 IGKV2D-28 IGKV2D-26 IGKV1D-43 IGKV1D-42 IGKV1D-39 IGKV1D-37 IGKV1D-33 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 IGKV1D-8 IGKV2-40 IGKV2-30 IGKV2-29 IGKV2-28 | 5.44e-51 | 83 | 83 | 30 | 351 |
| GeneFamily | C1-set domain containing | 4.05e-05 | 42 | 83 | 4 | 591 | |
| GeneFamily | Solute carriers | 4.57e-04 | 395 | 83 | 8 | 752 | |
| GeneFamily | Histocompatibility complex|C1-set domain containing | 1.08e-03 | 44 | 83 | 3 | 588 | |
| GeneFamily | Parkinson disease associated genes | 2.40e-03 | 16 | 83 | 2 | 672 | |
| GeneFamily | Claudins | 4.95e-03 | 23 | 83 | 2 | 488 | |
| GeneFamily | Calcium voltage-gated channel subunits | 6.30e-03 | 26 | 83 | 2 | 253 | |
| Coexpression | RASHI_RESPONSE_TO_IONIZING_RADIATION_6 | IGKV1-39 CUL2 IGKV1-27 IGKV1-13 IGKV1-12 IGKV1-9 IGKV1-5 IGKV2D-28 IGKV1D-43 IGKV1D-39 IGKV1D-33 IGKV1D-13 IGKV1D-12 IGKV1D-8 IGKV2-28 | 1.64e-18 | 132 | 97 | 15 | MM996 |
| Coexpression | HOEK_PBMC_INACTIVATED_INFLUENZA_ADULT_1DY_UP | 1.23e-07 | 13 | 97 | 4 | M41033 | |
| Coexpression | SALVADOR_MARTIN_PEDIATRIC_TBD_ANTI_TNF_THERAPY_NONRESPONDER_POST_TREATMENT_DN | 3.10e-07 | 16 | 97 | 4 | M41742 | |
| Coexpression | MATTIOLI_MGUS_VS_PCL | RUVBL1 IGKV2D-28 IGKV1D-39 IGKV1D-37 IGKV1D-17 IGKV1D-13 IGKV1D-8 | 4.75e-07 | 127 | 97 | 7 | M10973 |
| Coexpression | RUAN_RESPONSE_TO_TNF_UP | 1.00e-06 | 21 | 97 | 4 | MM651 | |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_PCA1_UP | 1.06e-06 | 143 | 97 | 7 | MM1056 | |
| Coexpression | RUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP | 2.10e-06 | 25 | 97 | 4 | MM672 | |
| Coexpression | SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_DN | 5.85e-06 | 32 | 97 | 4 | M2118 | |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_PCA1_UP | 6.28e-06 | 122 | 97 | 6 | M9399 | |
| Coexpression | PAL_PRMT5_TARGETS_DN | 8.45e-06 | 35 | 97 | 4 | MM674 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_CD8_POSITIVE_ALPHA_BETA_T_CELL_AGEING | 1.31e-05 | 39 | 97 | 4 | MM3758 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_B_CELL_AGEING | 2.14e-05 | 90 | 97 | 5 | MM3756 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_ENDOTHELIAL_CELL_OF_LYMPHATIC_VESSEL_AGEING | 2.66e-05 | 16 | 97 | 3 | MM3766 | |
| Coexpression | RASHI_RESPONSE_TO_IONIZING_RADIATION_6 | 3.08e-05 | 97 | 97 | 5 | M1560 | |
| Coexpression | WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_DN | 4.56e-05 | 19 | 97 | 3 | MM797 | |
| Coexpression | MIKKELSEN_NPC_ICP_WITH_H3K27ME3 | 4.56e-05 | 19 | 97 | 3 | MM862 | |
| Coexpression | TABULA_MURIS_SENIS_BLADDER_LEUKOCYTE_AGEING | 5.35e-05 | 20 | 97 | 3 | MM3682 | |
| Coexpression | TABULA_MURIS_SENIS_MARROW_HEMATOPOIETIC_PRECURSOR_CELL_AGEING | 6.68e-05 | 114 | 97 | 5 | MM3799 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_PULMONARY_INTERSTITIAL_FIBROBLAST_AGEING | 9.40e-05 | 24 | 97 | 3 | MM3773 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_KIDNEY_MESANGIAL_CELL_AGEING | 2.05e-04 | 31 | 97 | 3 | MM3729 | |
| CoexpressionAtlas | AravindRamakr_StemCell-HD_top-relative-expression-ranked_1000_k-means-cluster#3 | IGKV1-39 IGKV1-33 IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-9 IGKV1-6 IGKV1-5 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV2-30 IGKV2-28 | 4.05e-13 | 183 | 85 | 13 | Arv_SC-HD_1000_K3 |
| CoexpressionAtlas | AravindRamakr_StemCell-hypoxiaGrown_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_500_k-means-cluster#2 | IGKV1-39 IGKV1-33 IGKV1-27 IGKV1-17 IGKV1-12 IGKV1-9 IGKV1-5 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV2-30 IGKV2-28 | 2.26e-12 | 163 | 85 | 12 | Arv_SC-hpx_blastocyst_500_K2 |
| CoexpressionAtlas | AravindRamakr_StemCell-H9hpx_top-relative-expression-ranked_500_k-means-cluster#3 | IGKV1-39 IGKV1-33 IGKV1-27 IGKV1-17 IGKV1-12 IGKV1-9 IGKV1-5 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV2-30 IGKV2-28 | 5.24e-12 | 175 | 85 | 12 | Arv_SC-H9hpx_500_K3 |
| CoexpressionAtlas | AravindRamakr_StemCell_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_1000_k-means-cluster#5 | IGKV1-39 IGKV1-33 IGKV1-27 IGKV1-16 IGKV1-9 IGKV1-6 IGKV1-5 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV2-30 IGKV2-28 | 8.89e-12 | 183 | 85 | 12 | Arv_SC_fibroblast_1000_K5 |
| CoexpressionAtlas | PP_HSC_top-relative-expression-ranked_2500_k-means-cluster#3 | MPO IGKV1-39 IGKV1-27 CLDN18 IGKV1-17 IGKV1-12 IGKV1-9 IGKV1-6 PIGT IGKV2D-40 IGKV2D-30 IGKV1D-39 IGKV2-40 IGKV2-30 | 7.31e-11 | 339 | 85 | 14 | PP_HSC_2500_K3 |
| CoexpressionAtlas | AravindRamakr_StemCell-H9hpx_top-relative-expression-ranked_1000_k-means-cluster#4 | IGKV1-39 IGKV1-33 IGKV1-27 IGKV1-17 IGKV1-12 IGKV1-9 IGKV1-5 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV2-30 IGKV2-28 | 2.54e-10 | 244 | 85 | 12 | Arv_SC-H9hpx_1000_K4 |
| CoexpressionAtlas | AravindRamakr_StemCell-HD_top-relative-expression-ranked_500_k-means-cluster#2 | IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-5 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV2-30 IGKV2-28 | 1.92e-09 | 126 | 85 | 9 | Arv_SC-HD_500_K2 |
| CoexpressionAtlas | AravindRamakr_StemCell_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_500_k-means-cluster#3 | IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-5 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV2-30 IGKV2-28 | 4.59e-09 | 139 | 85 | 9 | Arv_SC_fibroblast_500_K3 |
| CoexpressionAtlas | AravindRamakr_StemCell-H9hpx_top-relative-expression-ranked_500 | IGKV1-39 IGKV1-33 IGKV1-27 IGKV1-17 IGKV1-12 IGKV1-9 IGKV1-5 CUZD1 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV2-30 IGKV2-28 | 7.66e-08 | 492 | 85 | 13 | Arv_SC-H9hpx_500 |
| CoexpressionAtlas | AravindRamakr_StemCell-hypoxiaGrown_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_500 | IGKV1-39 IGKV1-33 IGKV1-27 IGKV1-17 IGKV1-12 IGKV1-9 IGKV1-5 CUZD1 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV2-30 IGKV2-28 | 7.66e-08 | 492 | 85 | 13 | Arv_SC-hpx_blastocyst_500 |
| CoexpressionAtlas | AravindRamakr_StemCell-hypoxiaGrown_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_1000_k-means-cluster#2 | IGKV1-39 IGKV1-33 IGKV1-27 IGKV1-9 IGKV1-5 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV2-30 IGKV2-28 | 1.10e-07 | 266 | 85 | 10 | Arv_SC-hpx_blastocyst_1000_K2 |
| CoexpressionAtlas | AravindRamakr_StemCell_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_1000 | IGKV1-39 IGKV1-33 IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-9 IGKV1-6 KIRREL2 IGKV1-5 CUZD1 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV2-30 IGKV2-28 | 1.59e-06 | 986 | 85 | 16 | Arv_SC_fibroblast_1000 |
| CoexpressionAtlas | AravindRamakr_StemCell-HD_top-relative-expression-ranked_1000 | IGKV1-39 IGKV1-33 IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-9 IGKV1-6 KIRREL2 IGKV1-5 CUZD1 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV2-30 IGKV2-28 | 1.59e-06 | 986 | 85 | 16 | Arv_SC-HD_1000 |
| CoexpressionAtlas | PP_HSC_top-relative-expression-ranked_2500_k-means-cluster#2 | IGKV1-33 IGKV1-16 EREG TMEM14A IGKV1-5 AIG1 CUZD1 IGKV2D-28 IGKV2-28 | 6.12e-06 | 325 | 85 | 9 | PP_HSC_2500_K2 |
| CoexpressionAtlas | ratio_induced-Ectoderm_vs_StemCell_top-relative-expression-ranked_2500_k-means-cluster#3 | IGKV1-39 IGKV1-27 CLDN18 IGKV1-17 IGKV1-12 IGKV1-9 UTS2R TMEM8B IGKV1-5 IGKV2D-28 IGKV1D-39 IGKV2-30 IGKV2-28 CA4 | 6.42e-06 | 848 | 85 | 14 | ratio_ECTO_vs_SC_2500_K3 |
| CoexpressionAtlas | AravindRamakr_StemCell-H9hpx_top-relative-expression-ranked_2500_k-means-cluster#1 | IGKV1-39 IGKV1-27 IGKV1-17 IGKV1-12 IGKV1-9 IGKV1-6 IGKV2D-30 IGKV1D-39 IGKV2-30 | 7.09e-06 | 331 | 85 | 9 | Arv_SC-H9hpx_2500_K1 |
| CoexpressionAtlas | AravindRamakr_StemCell-H9hpx_top-relative-expression-ranked_1000 | IGKV1-39 IGKV1-33 IGKV1-27 IGKV1-17 IGKV1-12 IGKV1-9 IGKV1-6 KIRREL2 IGKV1-5 CUZD1 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV2-30 IGKV2-28 | 7.81e-06 | 987 | 85 | 15 | Arv_SC-H9hpx_1000 |
| CoexpressionAtlas | AravindRamakr_StemCell-hypoxiaGrown_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_1000 | IGKV1-39 IGKV1-33 IGKV1-27 IGKV1-17 IGKV1-12 IGKV1-9 IGKV1-6 KIRREL2 IGKV1-5 CUZD1 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV2-30 IGKV2-28 | 7.81e-06 | 987 | 85 | 15 | Arv_SC-hpx_blastocyst_1000 |
| CoexpressionAtlas | AravindRamakr_StemCell_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_2500_k-means-cluster#5 | IGKV1-39 IGKV1-27 IGKV1-17 IGKV1-12 IGKV1-9 IGKV1-6 IGKV2D-30 IGKV1D-39 IGKV2-30 | 9.01e-06 | 341 | 85 | 9 | Arv_SC_fibroblast_2500_K5 |
| CoexpressionAtlas | AravindRamakr_StemCell-HD_top-relative-expression-ranked_500 | IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-5 CUZD1 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV2-30 IGKV2-28 | 2.55e-05 | 489 | 85 | 10 | Arv_SC-HD_500 |
| CoexpressionAtlas | AravindRamakr_StemCell_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_500 | IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-5 CUZD1 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV2-30 IGKV2-28 | 2.55e-05 | 489 | 85 | 10 | Arv_SC_fibroblast_500 |
| CoexpressionAtlas | AravindRamakr_StemCell-HD_top-relative-expression-ranked_2500_k-means-cluster#4 | IGKV1-39 IGKV1-27 IGKV1-17 IGKV1-12 IGKV1-9 IGKV1-6 IGKV2D-30 IGKV1D-39 | 3.83e-05 | 315 | 85 | 8 | Arv_SC-HD_2500_K4 |
| CoexpressionAtlas | geo_heart_top-relative-expression-ranked_2500_k-means-cluster#2 | IGKV1-39 IGKV1-33 IGKV1-27 SERPINA3 IGKV1-9 IGKV1-6 AZGP1 SLC1A3 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV2-30 IGKV2-28 PINK1 CA4 | 3.93e-05 | 1133 | 85 | 15 | geo_heart_2500_K2 |
| CoexpressionAtlas | AravindRamakr_StemCell-hypoxiaGrown_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_2500_k-means-cluster#3 | IGKV1-39 IGKV1-27 IGKV1-17 IGKV1-12 IGKV1-6 IGKV1D-39 IGKV2-30 | 4.08e-04 | 337 | 85 | 7 | Arv_SC-hpx_blastocyst_2500_K3 |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-B-B_plasma|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | IGKV1-39 IGKV1-37 IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-13 IGKV1-12 IGKV1-9 IGKV1-6 UTS2R TLR9 IGKV1-5 IGKV2D-30 IGKV1D-43 IGKV1D-39 IGKV1D-37 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 IGKV1D-8 IGKV2-28 | 3.82e-31 | 194 | 104 | 22 | 6ef4aeb8d8e35e4df58ff2a8256caa2113291de9 |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | IGKV1-39 IGKV1-37 IGKV1-33 IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-13 IGKV1-12 IGKV1-9 IGKV1-6 TLR9 IGKV1-5 IGKV2D-28 IGKV1D-43 IGKV1D-39 IGKV1D-37 IGKV1D-33 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 IGKV1D-8 | 4.30e-31 | 195 | 104 | 22 | f3f7f1a77a1edd2b50a8211c76fe289738eb04cf |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-B|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | IGKV1-39 IGKV1-33 IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-13 IGKV1-12 IGKV1-9 IGKV1-6 IGKV1-5 IGKV2D-30 IGKV2D-28 IGKV1D-43 IGKV1D-39 IGKV1D-33 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 IGKV1D-8 IGKV2-29 IGKV2-28 | 5.43e-31 | 197 | 104 | 22 | 9fe1b757f76c2d43d39aa9ac500eaba98723985c |
| ToppCell | COPD-Lymphoid-B_Plasma|World / Disease state, Lineage and Cell class | IGKV1-39 IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-13 IGKV1-12 IGKV1-9 IGKV1-5 IGKV2D-40 IGKV2D-30 IGKV2D-29 IGKV2D-28 IGKV1D-39 IGKV1D-33 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-8 IGKV2-30 IGKV2-29 IGKV2-28 | 2.74e-30 | 175 | 104 | 21 | d73ee324479172501481b54967a0f3bd870fcf3a |
| ToppCell | Tracheal-10x5prime-Immune_Lymphocytic-B-B_plasma|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | IGKV1-39 IGKV1-37 IGKV1-17 IGKV1-16 IGKV1-13 IGKV1-12 IGKV1-6 TLR9 IGKV2D-30 IGKV2D-28 IGKV2D-26 IGKV1D-43 IGKV1D-39 IGKV1D-17 IGKV1D-13 IGKV1D-12 IGKV1D-8 IGKV2-40 IGKV2-30 IGKV2-29 IGKV2-28 | 2.34e-29 | 193 | 104 | 21 | 282b47dae6043eabb1e13d41d91c07b5ec21cd65 |
| ToppCell | Biopsy_IPF-Immune-Plasma_cells|Biopsy_IPF / Sample group, Lineage and Cell type | IGKV1-39 IGKV1-37 IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-13 IGKV1-12 IGKV1-9 IGKV1-6 IGKV1-5 IGKV2D-30 IGKV2D-28 IGKV1D-43 IGKV1D-39 IGKV1D-33 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-8 IGKV2-29 | 2.08e-27 | 196 | 104 | 20 | a1b6a8000b86efcb07843998aa3a49bb1f54bcda |
| ToppCell | IPF-Lymphoid-B_Plasma|IPF / Disease state, Lineage and Cell class | IGKV1-39 IGKV1-37 IGKV1-33 IGKV1-17 IGKV1-13 IGKV1-12 IGKV1-6 IGKV1-5 IGKV2D-30 IGKV2D-28 IGKV1D-43 IGKV1D-39 IGKV1D-33 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 IGKV1D-8 IGKV2-28 | 1.49e-26 | 176 | 104 | 19 | e4f33f6cd140dd4fa3002bcd65ac8005d27865d1 |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Plasma_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | IGKV1-39 IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-9 IGKV1-6 IGKV1-5 IGKV2D-29 IGKV2D-28 IGKV1D-43 IGKV1D-39 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 IGKV1D-8 IGKV2-30 IGKV2-29 | 6.74e-26 | 190 | 104 | 19 | 79ee6d10dfbb775da149a1104da5823cf63bbb46 |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Plasma_cells-IgA_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | IGKV1-39 IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-9 IGKV1-6 IGKV1-5 IGKV2D-29 IGKV2D-28 IGKV1D-43 IGKV1D-39 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 IGKV1D-8 IGKV2-30 IGKV2-29 | 6.74e-26 | 190 | 104 | 19 | 18762ce78ed0b206ade19e1c8ff76a2647489f68 |
| ToppCell | Bronchial-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | IGKV1-39 IGKV1-33 IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-13 IGKV1-12 IGKV1-6 UTS2R TLR9 IGKV1-5 IGKV2D-30 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-13 IGKV1D-12 IGKV1D-8 IGKV2-30 | 1.24e-25 | 196 | 104 | 19 | fec21383435779bf4c632decd3d29c6ca7baebfb |
| ToppCell | Tracheal-10x5prime-Immune_Lymphocytic-B|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | IGKV1-39 IGKV1-37 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-6 TLR9 IGKV2D-30 IGKV2D-26 IGKV1D-39 IGKV1D-33 IGKV1D-17 IGKV1D-13 IGKV1D-12 IGKV1D-8 IGKV2-30 IGKV2-29 IGKV2-28 | 1.37e-25 | 197 | 104 | 19 | 2662138671262b30508c5759038bcdcfe6551696 |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast-Plasmablast|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-9 IGKV1-6 IGKV1-5 IGKV2D-40 IGKV2D-30 IGKV1D-39 IGKV1D-37 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 IGKV1D-8 IGKV2-40 IGKV2-30 | 1.28e-24 | 179 | 104 | 18 | 494febe77c6d4e6a2c6f0928bbf4c84b0301f188 |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-13 IGKV1-12 IGKV1-9 IGKV1-6 IGKV1-5 IGKV2D-30 IGKV2D-28 IGKV1D-43 IGKV1D-39 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 IGKV1D-8 IGKV2-28 | 5.18e-24 | 193 | 104 | 18 | 34f6c13884fdf7f8a87f942fcb36a58cfac3f65d |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | IGKV1-17 IGKV1-16 IGKV1-9 IGKV1-6 IGKV1-5 IGKV2D-40 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV1D-37 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 IGKV1D-8 IGKV2-30 IGKV2-28 | 7.33e-23 | 179 | 104 | 17 | 837ed81f18257f444eaeadc4fac89deedd4e3061 |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | IGKV1-17 IGKV1-16 IGKV1-9 IGKV1-6 IGKV1-5 IGKV2D-40 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV1D-37 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 IGKV1D-8 IGKV2-30 IGKV2-28 | 7.33e-23 | 179 | 104 | 17 | b6ee4f41d8fb5f047b7bdd8489dda0a89fc6d43f |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | IGKV1-39 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-9 IGKV1-6 IGKV1-5 IGKV2D-30 IGKV2D-29 IGKV2D-28 IGKV1D-39 IGKV1D-33 IGKV1D-17 IGKV1D-8 IGKV2-30 IGKV2-29 IGKV2-28 | 1.08e-22 | 183 | 104 | 17 | cf5c98f451a568308c52da5c926543dd4836c6b2 |
| ToppCell | Biopsy_Other_PF-Immune-Plasma_cells|Biopsy_Other_PF / Sample group, Lineage and Cell type | IGKV1-39 IGKV1-37 IGKV1-27 IGKV1-16 IGKV1-12 IGKV1-6 TLR9 IGKV1-5 IGKV2D-30 IGKV2D-28 IGKV2D-26 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-13 IGKV1D-8 IGKV2-30 | 3.26e-22 | 195 | 104 | 17 | d0305c6a68c9e361507b04db94f86873085d49b3 |
| ToppCell | Tracheal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | IGKV1-39 IGKV1-37 IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-6 IGKV2D-30 IGKV2D-28 IGKV2D-26 IGKV1D-39 IGKV1D-17 IGKV1D-13 IGKV1D-12 IGKV2-30 IGKV2-29 IGKV2-28 | 3.26e-22 | 195 | 104 | 17 | df009b18898c10686f75cf72b4ec0eff18f5bb50 |
| ToppCell | Bronchial-10x5prime-Immune_Lymphocytic-B-B_plasma|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | IGKV1-39 IGKV1-33 IGKV1-27 IGKV1-16 IGKV1-13 IGKV1-12 IGKV1-6 IGKV1-5 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-13 IGKV1D-12 IGKV1D-8 IGKV2-28 | 3.56e-22 | 196 | 104 | 17 | c38e7f533c619afe008de0e99042f7180c2da918 |
| ToppCell | normal_Lung-B_lymphocytes-MALT_B_cells|normal_Lung / Location, Cell class and cell subclass | IGKV1-39 IGKV1-16 IGKV1-12 IGKV1-9 IGKV1-6 IGKV1-5 IGKV2D-30 IGKV2D-29 IGKV2D-26 IGKV1D-43 IGKV1D-39 IGKV1D-33 IGKV1D-13 IGKV1D-8 IGKV2-30 IGKV2-29 | 5.54e-22 | 159 | 104 | 16 | fbd0131b66f4267f7b0d6c3ad874ad097b859074 |
| ToppCell | Control-Lymphoid-B_Plasma|Control / Disease state, Lineage and Cell class | IGKV1-39 IGKV1-16 IGKV1-13 IGKV1-12 IGKV1-5 IGKV2D-30 IGKV2D-29 IGKV2D-26 IGKV1D-43 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-13 IGKV1D-8 IGKV2-30 IGKV2-29 | 2.02e-21 | 172 | 104 | 16 | 61e33836b8cb0f347f3e699eb587a37073b6fa4c |
| ToppCell | Control-Lymphoid_P-Plasmablast|Control / Disease group, lineage and cell class | IGKV1-33 IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-9 IGKV1-6 IGKV1-5 IGKV2D-30 IGKV1D-42 IGKV1D-39 IGKV1D-37 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 IGKV2-28 | 2.95e-21 | 176 | 104 | 16 | 4b4416f342b732d2cc60133838728880326257d8 |
| ToppCell | Control-Lymphoid_P|Control / Disease group, lineage and cell class | IGKV1-33 IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-9 IGKV1-6 IGKV1-5 IGKV2D-30 IGKV1D-42 IGKV1D-39 IGKV1D-37 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 IGKV2-28 | 2.95e-21 | 176 | 104 | 16 | d895a6b295cd649273ff80ad7785a3e0ae4c728a |
| ToppCell | healthy_donor-Lymphocytic-Plasma_cell-IgA_Plasmablast|healthy_donor / Disease condition, Lineage, Cell class and subclass | IGKV1-33 IGKV1-27 IGKV1-17 IGKV1-9 IGKV1-6 IGKV1-5 IGKV2D-28 IGKV1D-43 IGKV1D-42 IGKV1D-39 IGKV1D-37 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 IGKV2-28 | 7.29e-21 | 186 | 104 | 16 | e2c050ba02e1f84f0b7258dc92e7ff6ab349ff67 |
| ToppCell | Tracheal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | IGKV1-37 IGKV1-17 IGKV1-16 IGKV1-13 IGKV1-12 IGKV1-6 TLR9 IGKV1-5 IGKV2D-30 IGKV1D-43 IGKV1D-39 IGKV1D-17 IGKV1D-12 IGKV1D-8 IGKV2-40 IGKV2-28 | 1.45e-20 | 194 | 104 | 16 | a4a70369541876e1192df8828b63e3d1746ae3d9 |
| ToppCell | Bronchial-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | IGKV1-39 IGKV1-33 IGKV1-16 IGKV1-12 IGKV1-6 IGKV1-5 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV1D-37 IGKV1D-33 IGKV1D-16 IGKV1D-13 IGKV1D-8 IGKV2-40 IGKV2-28 | 1.58e-20 | 195 | 104 | 16 | 13f4ee21568fd747608412d33559d10561dbb3c8 |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | IGKV1-17 IGKV1-16 IGKV1-9 IGKV1-6 IGKV1-5 IGKV2D-40 IGKV2D-30 IGKV1D-37 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 IGKV1D-8 IGKV2-30 IGKV2-28 | 1.61e-19 | 177 | 104 | 15 | 4c434a7b7cc54cf4dac996bbc3f5124d9ef9a9cd |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | IGKV1-17 IGKV1-16 IGKV1-9 IGKV1-6 IGKV1-5 IGKV2D-40 IGKV2D-30 IGKV1D-37 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 IGKV1D-8 IGKV2-30 IGKV2-28 | 1.61e-19 | 177 | 104 | 15 | d746122bf8d208c3aa4d156e8c12d0a0e555c6e5 |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | IGKV1-17 IGKV1-16 IGKV1-9 IGKV1-6 IGKV1-5 IGKV2D-40 IGKV2D-30 IGKV1D-37 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 IGKV1D-8 IGKV2-30 IGKV2-28 | 1.61e-19 | 177 | 104 | 15 | fc40918825b7e1eb6861df59dfca944778a64b98 |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | IGKV1-39 IGKV1-17 IGKV1-12 IGKV1-5 IGKV2D-30 IGKV2D-28 IGKV1D-43 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-13 IGKV1D-12 IGKV1D-8 IGKV2-30 IGKV2-28 | 3.16e-19 | 185 | 104 | 15 | 08bc817908076734d66f2805cb954141f2cc5a18 |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | IGKV1-39 IGKV1-17 IGKV1-12 IGKV1-5 IGKV2D-30 IGKV2D-28 IGKV1D-43 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-13 IGKV1D-12 IGKV1D-8 IGKV2-30 IGKV2-28 | 3.16e-19 | 185 | 104 | 15 | 1704a12153a9b107bf03ecccd1a036cf61334d7a |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | IGKV1-39 IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-9 IGKV1-6 IGKV1-5 IGKV1D-43 IGKV1D-39 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-8 IGKV2-30 IGKV2-29 | 5.14e-19 | 191 | 104 | 15 | d1d30279ed4612b4f62c225d9eabf0b8a7a09d11 |
| ToppCell | 368C-Lymphocytic-Plasma_cell-|368C / Donor, Lineage, Cell class and subclass (all cells) | IGKV1-39 IGKV1-37 IGKV1-17 IGKV1-12 IGKV1-6 IGKV1-5 IGKV2D-30 IGKV2D-29 IGKV1D-39 IGKV1D-13 IGKV1D-12 IGKV1D-8 IGKV2-30 IGKV2-29 | 2.09e-18 | 162 | 104 | 14 | c21a54310b239d999bbc9d8fb5e8fda16e0bc336 |
| ToppCell | 368C-Lymphocytic-Plasma_cell|368C / Donor, Lineage, Cell class and subclass (all cells) | IGKV1-39 IGKV1-37 IGKV1-17 IGKV1-12 IGKV1-6 IGKV1-5 IGKV2D-30 IGKV2D-29 IGKV1D-39 IGKV1D-13 IGKV1D-12 IGKV1D-8 IGKV2-30 IGKV2-29 | 2.09e-18 | 162 | 104 | 14 | f945688815229c8386cbcbf46deee7df316fa8d3 |
| ToppCell | TCGA-Stomach-Solid_Tissue_Normal-Stomach_normal_tissue-Stomach_normal_tissue-2|TCGA-Stomach / Sample_Type by Project: Shred V9 | IGKV1-37 IGKV1-33 IGKV2D-30 IGKV2D-28 IGKV2D-26 IGKV1D-42 IGKV1D-37 IGKV1D-33 IGKV1D-17 IGKV1D-12 IGKV1D-8 IGKV2-40 IGKV2-28 | 2.75e-18 | 124 | 104 | 13 | 9d62f997a1a389386e8d83652bdf109c2a1c96d8 |
| ToppCell | BAL-Mild-Lymphocyte-B|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | IGKV1-39 IGKV1-16 IGKV1-12 IGKV1-9 IGKV1-6 TLR9 IGKV1-5 IGKV2D-30 IGKV2D-28 IGKV1D-39 H2BW2 IGKV1D-12 IGKV2-30 IGKV2-29 | 3.82e-18 | 169 | 104 | 14 | 307571e57c3bfdf15f0fe1a8b36585e8e4f8a207 |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | IGKV1-39 IGKV1-27 IGKV1-16 IGKV1-12 IGKV1-6 IGKV2D-30 IGKV2D-28 IGKV1D-43 IGKV1D-39 IGKV1D-33 IGKV1D-8 IGKV2-30 IGKV2-29 IGKV2-28 | 5.33e-18 | 173 | 104 | 14 | 7e6bfe85f60834f317941b70d6e0dc3bd527d293 |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | IGKV1-39 IGKV1-37 IGKV1-33 IGKV1-12 IGKV1-5 IGKV2D-30 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-13 IGKV1D-12 IGKV1D-8 IGKV2-30 IGKV2-28 | 9.36e-18 | 180 | 104 | 14 | e3877f6ef5f54ff689058b4c996ab1851822f871 |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-Plasma_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | IGKV1-39 IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-9 IGKV1-6 IGKV1-5 IGKV2D-28 IGKV1D-39 IGKV1D-33 IGKV1D-17 IGKV1D-13 IGKV1D-8 IGKV2-30 | 1.38e-17 | 185 | 104 | 14 | 0fff2608f507e019ebb69c27e58fd5be3b049bef |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-Plasma_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | IGKV1-39 IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-9 IGKV1-6 IGKV1-5 IGKV2D-28 IGKV1D-39 IGKV1D-33 IGKV1D-17 IGKV1D-13 IGKV1D-8 IGKV2-30 | 1.38e-17 | 185 | 104 | 14 | 79edc1eeb7b5b9123961ac3ecf398ee68d9dddb9 |
| ToppCell | healthy_donor-Lymphocytic-Plasma_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | IGKV1-17 IGKV1-9 IGKV1-6 IGKV1-5 IGKV2D-30 IGKV1D-42 IGKV1D-39 IGKV1D-37 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 IGKV2-30 IGKV2-28 | 1.73e-17 | 188 | 104 | 14 | bd53b0371154cff680226897b61c9809a239d1b6 |
| ToppCell | 3'_v3-blood-Lymphocytic_B_plasma-Plasma_cells|blood / Manually curated celltypes from each tissue | IGKV1-17 IGKV1-12 IGKV1-5 IGKV2D-29 IGKV2D-26 IGKV1D-33 IGKV1D-17 IGKV1D-13 IGKV1D-8 IGKV2-40 IGKV2-30 IGKV2-29 IGKV2-28 | 1.23e-16 | 165 | 104 | 13 | 1c0c24fe252b761cf879b83562e23c02f0b6489f |
| ToppCell | 367C-Lymphocytic-Plasma_cell-|367C / Donor, Lineage, Cell class and subclass (all cells) | IGKV1-39 IGKV1-37 IGKV1-12 IGKV1-6 IGKV1-5 IGKV2D-30 IGKV2D-29 IGKV2D-28 IGKV1D-43 IGKV1D-39 IGKV1D-12 IGKV2-30 IGKV2-29 | 1.44e-16 | 167 | 104 | 13 | f2185eb72f0137136f6d71af2a70168fded6c940 |
| ToppCell | 367C-Lymphocytic-Plasma_cell|367C / Donor, Lineage, Cell class and subclass (all cells) | IGKV1-39 IGKV1-37 IGKV1-12 IGKV1-6 IGKV1-5 IGKV2D-30 IGKV2D-29 IGKV2D-28 IGKV1D-43 IGKV1D-39 IGKV1D-12 IGKV2-30 IGKV2-29 | 1.44e-16 | 167 | 104 | 13 | 5e768cf24699893e05d1bcb1c92dba2336943a64 |
| ToppCell | 10x5'-GI_large-bowel|World / Manually curated celltypes from each tissue | IGKV1-39 IGKV1-16 IGKV1-13 IGKV1-12 IGKV1-9 IGKV1-6 IGKV1-5 IGKV2D-28 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-8 CA4 | 1.56e-16 | 168 | 104 | 13 | 1290c909655bc37f6b8bf216d18127a21b99e9c0 |
| ToppCell | metastatic_Brain-B_lymphocytes-Plasma_cells|metastatic_Brain / Location, Cell class and cell subclass | IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-9 IGKV1-6 IGKV1-5 IGKV2D-29 IGKV2D-28 IGKV1D-43 IGKV1D-39 IGKV1D-17 IGKV1D-8 | 1.82e-16 | 170 | 104 | 13 | 53634da9e9c72f6400639954c286c6e38ea5a188 |
| ToppCell | wk_08-11-Hematologic_Lymphocytic-B|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-13 IGKV2D-30 IGKV2D-26 IGKV1D-43 IGKV1D-39 IGKV1D-33 IGKV1D-13 IGKV1D-8 IGKV2-30 IGKV2-29 | 2.13e-16 | 172 | 104 | 13 | d1ab8f493b70ec995281f9fb0991f1d3aa7b928f |
| ToppCell | (2)_Plasma_cells|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | IGKV1-39 IGKV1-37 IGKV1-17 IGKV1-12 IGKV1-6 IGKV1-5 IGKV2D-30 IGKV2D-29 IGKV2D-28 IGKV1D-39 IGKV1D-16 IGKV1D-8 IGKV2-30 | 3.10e-16 | 177 | 104 | 13 | ed3c936bb69f9bc7291b4f6cde1d204078117c48 |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | IGKV1-39 IGKV1-12 IGKV1-9 IGKV1-5 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV1D-33 IGKV1D-13 IGKV1D-8 IGKV2-30 IGKV2-29 IGKV2-28 | 3.34e-16 | 178 | 104 | 13 | 107dae8b00c4257697a63700e72bb434cdb8406f |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | IGKV1-39 IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-9 IGKV1-6 IGKV1-5 IGKV2D-30 IGKV1D-43 IGKV1D-17 IGKV1D-13 IGKV2-30 | 4.15e-16 | 181 | 104 | 13 | e47664a264a2c37390d1668ce04eef2e0172f4cb |
| ToppCell | cellseq-Immune-Lymphocytic_B-Lymphocytic_B-Plasma|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | IGKV1-39 IGKV1-12 IGKV1-5 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-13 IGKV1D-12 IGKV1D-8 IGKV2-30 IGKV2-28 | 4.80e-16 | 183 | 104 | 13 | 5ab4aa0304b832f98fff89b6c24ad5b7dd014c11 |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | IGKV1-39 IGKV1-17 IGKV1-12 IGKV1-9 IGKV1-6 IGKV1-5 IGKV2D-30 IGKV2D-29 IGKV2D-28 IGKV1D-39 IGKV1D-8 IGKV2-30 IGKV2-29 | 5.53e-16 | 185 | 104 | 13 | 6ec009e48e50471c28e914c402f500e56a88f8f2 |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | IGKV1-39 IGKV1-17 IGKV1-12 IGKV1-9 IGKV1-6 IGKV1-5 IGKV2D-30 IGKV2D-29 IGKV2D-28 IGKV1D-39 IGKV1D-8 IGKV2-30 IGKV2-29 | 5.53e-16 | 185 | 104 | 13 | f49ad6401b2abd089e30eba245b11b5031ea2318 |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-lymphocytic-B_lymphocytic-plasma_cell|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | IGKV1-39 IGKV1-17 IGKV1-16 IGKV1-13 IGKV1-9 IGKV1-6 IGKV1-5 IGKV2D-29 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-13 IGKV1D-8 | 7.32e-16 | 189 | 104 | 13 | 5a42be62552d912d0abf68f00d75ac80bbd69f2c |
| ToppCell | BAL-Mild-Lymphocyte-B-B_cell-B_cell-B_activate-7|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | IGKV1-39 IGKV1-16 IGKV1-12 IGKV1-9 IGKV1-6 TLR9 IGKV1-5 IGKV2D-28 IGKV1D-39 H2BW2 IGKV1D-12 IGKV2-29 | 7.31e-15 | 170 | 104 | 12 | ee2ee67d90ae4596de8ccd620e37c82cf51651d4 |
| ToppCell | BAL-Mild-Lymphocyte-B-B_cell-B_cell|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | IGKV1-39 IGKV1-16 IGKV1-12 IGKV1-9 IGKV1-6 TLR9 IGKV1-5 IGKV2D-28 IGKV1D-39 H2BW2 IGKV1D-12 IGKV2-29 | 7.31e-15 | 170 | 104 | 12 | d7ca0c6ce5d2b7de99346f87e07aa7fe728fa08a |
| ToppCell | BAL-Mild-Lymphocyte-B-B_cell|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | IGKV1-39 IGKV1-16 IGKV1-12 IGKV1-9 IGKV1-6 TLR9 IGKV1-5 IGKV2D-28 IGKV1D-39 H2BW2 IGKV1D-12 IGKV2-29 | 7.31e-15 | 170 | 104 | 12 | 52787f6d529c285d9f0c04cc022710ead5b89b3f |
| ToppCell | IPF-Lymphoid-B_Plasma|World / Disease state, Lineage and Cell class | IGKV1-39 IGKV1-37 IGKV1-13 IGKV1-12 IGKV1-5 IGKV2D-30 IGKV2D-28 IGKV1D-43 IGKV1D-33 IGKV1D-17 IGKV1D-12 IGKV1D-8 | 1.11e-14 | 176 | 104 | 12 | cc0cab6487df6867b529596ec94f55d31aa6ca36 |
| ToppCell | VE-plasma|VE / Condition, Cell_class and T cell subcluster | IGKV1-39 IGKV1-16 IGKV1-13 IGKV1-12 IGKV1-6 DDR2 IGKV2D-30 IGKV2D-28 IGKV1D-33 IGKV1D-13 IGKV1D-12 IGKV2-30 | 1.19e-14 | 177 | 104 | 12 | 0c1cc0834de55717cb4f69d020339060ce2c9a03 |
| ToppCell | VE-plasma-|VE / Condition, Cell_class and T cell subcluster | IGKV1-39 IGKV1-16 IGKV1-13 IGKV1-12 IGKV1-6 DDR2 IGKV2D-30 IGKV2D-28 IGKV1D-33 IGKV1D-13 IGKV1D-12 IGKV2-30 | 1.19e-14 | 177 | 104 | 12 | 3a3c94cf30012e2aa266bc4d7fe772e45fa90f6d |
| ToppCell | BAL-Mild-Lymphocyte-B|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | IGKV1-39 IGKV1-16 IGKV1-12 IGKV1-9 IGKV1-6 TLR9 IGKV1-5 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV2-30 IGKV2-29 | 1.56e-14 | 181 | 104 | 12 | 700adfb41e4e377530f0dd31be89e12f109f3469 |
| ToppCell | Mild-Lymphoid-B|Mild / Condition, Lineage, Cell class and cell subclass | IGKV1-39 IGKV1-33 IGKV1-27 IGKV1-16 IGKV1-12 IGKV1-9 IGKV1-6 TLR9 IGKV1-5 IGKV2D-28 IGKV1D-39 IGKV2-29 | 1.78e-14 | 183 | 104 | 12 | 9b64d2d143525e6f48a191facfd101462ff36324 |
| ToppCell | Mild-Lymphoid-B-|Mild / Condition, Lineage, Cell class and cell subclass | IGKV1-39 IGKV1-33 IGKV1-27 IGKV1-16 IGKV1-12 IGKV1-9 IGKV1-6 TLR9 IGKV1-5 IGKV2D-28 IGKV1D-39 IGKV2-29 | 1.78e-14 | 183 | 104 | 12 | b5740f05a4dcdbbf24f7bf7a3f57ac01a5e75f60 |
| ToppCell | IPF-Lymphoid-B_Plasma|Lymphoid / Disease state, Lineage and Cell class | IGKV1-39 IGKV1-17 IGKV1-13 IGKV1-12 IGKV1-5 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV1D-33 IGKV1D-17 IGKV1D-12 IGKV1D-8 | 2.16e-14 | 186 | 104 | 12 | f9c21daf905d0bb0e0e769ca4bb069ea4b1ba25b |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | IGKV1-39 IGKV1-17 IGKV1-12 IGKV1-9 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV1D-33 IGKV1D-13 IGKV1D-8 IGKV2-30 IGKV2-28 | 2.46e-14 | 188 | 104 | 12 | 6844cebca177fdf38b21a40d606230a033717a3a |
| ToppCell | Tracheal-10x3prime_v2-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | IGKV1-27 IGKV1-12 IGKV1-9 IGKV2D-30 IGKV2D-29 IGKV2D-28 IGKV1D-43 IGKV1D-39 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV2-30 | 2.97e-14 | 191 | 104 | 12 | da4062a0f6d0af6d330acf11da216c64b0fa7c73 |
| ToppCell | COVID_vent-Lymphocytic-Plasma_cell-IgM_Plasmablast|COVID_vent / Disease condition, Lineage, Cell class and subclass | IGKV1-39 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-9 IGKV1-5 IGKV2D-30 IGKV2D-29 IGKV2D-28 IGKV1D-39 IGKV1D-17 IGKV2-30 | 4.05e-14 | 196 | 104 | 12 | 026a06d8d2089806823e6f6453d3ede84ae93bc6 |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-B-B_cell-B_naive|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | IGKV1-39 IGKV1-37 IGKV1-33 IGKV1-12 IGKV1-5 IGKV2D-30 IGKV2D-29 IGKV2D-28 IGKV2D-26 IGKV1D-33 IGKV2-29 IGKV2-28 | 4.86e-14 | 199 | 104 | 12 | 8e02d3a066e79e0f2024a10738e0ea070513ef19 |
| ToppCell | tumor_Lymph_Node_/_Brain-B_lymphocytes-MALT_B_cells|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-9 IGKV1-6 IGKV1-5 IGKV2D-28 IGKV1D-39 IGKV1D-37 IGKV1D-33 | 1.27e-13 | 159 | 104 | 11 | 204e5a675f4684c9570c24c8d34bbf632fd8164a |
| ToppCell | metastatic_Brain-B_lymphocytes-MALT_B_cells|metastatic_Brain / Location, Cell class and cell subclass | IGKV1-39 IGKV1-27 IGKV1-17 IGKV1-12 IGKV1-9 IGKV1-6 IGKV1-5 IGKV1D-39 IGKV1D-13 IGKV1D-12 IGKV2-30 | 3.90e-13 | 176 | 104 | 11 | 50e207403d48ce1b55a78897adb5519a2430a626 |
| ToppCell | COPD-Lymphoid-B_Plasma|COPD / Disease state, Lineage and Cell class | IGKV1-39 IGKV1-17 IGKV1-13 IGKV1-12 IGKV1-5 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV1D-17 IGKV1D-8 IGKV2-30 | 4.15e-13 | 177 | 104 | 11 | 1b872d3b1e0fca138362098590a634d748dfca60 |
| ToppCell | 3'_v3-blood-Lymphocytic_B_plasma|blood / Manually curated celltypes from each tissue | IGKV1-17 IGKV1-12 IGKV1-6 IGKV1-5 IGKV2D-30 IGKV2D-29 IGKV1D-13 IGKV1D-8 IGKV2-40 IGKV2-30 IGKV2-28 | 5.98e-13 | 183 | 104 | 11 | 2477183a290b2c45b6fa091ed76969a3826fe3d9 |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | IGKV1-39 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-9 IGKV1-5 IGKV2D-28 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-8 | 1.20e-12 | 195 | 104 | 11 | 2d18f08f33f3b261c77b8adf87d1a184cc6d7400 |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-B-B_cell|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-12 IGKV1-5 IGKV2D-30 IGKV2D-29 IGKV2D-28 IGKV1D-33 IGKV2-29 IGKV2-28 | 1.34e-12 | 197 | 104 | 11 | 76465bb2408c7c75f694e8f7cf1a606b796afc3a |
| ToppCell | Biopsy_Control_(H.)-Immune-Plasma_cells|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | IGKV1-39 IGKV1-12 TLR9 IGKV2D-30 IGKV2D-28 IGKV1D-39 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-8 IGKV2-30 | 1.34e-12 | 197 | 104 | 11 | 275f38ed7e477000e864cecf9b7d49ae134c3b6a |
| ToppCell | COVID_non-vent-Lymphocytic-Plasma_cell-IgG_Plasmablast|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | IGKV1-39 IGKV1-33 IGKV1-27 IGKV1-17 IGKV1-12 IGKV1-9 IGKV1-5 IGKV1D-39 IGKV1D-33 IGKV1D-13 IGKV1D-8 | 1.34e-12 | 197 | 104 | 11 | b754fad4f3caae6de95df901fd96ea8697fe41b1 |
| ToppCell | metastatic_Lymph_Node-B_lymphocytes-Plasma_cells|metastatic_Lymph_Node / Location, Cell class and cell subclass | IGKV1-37 IGKV1-27 IGKV1-16 IGKV1-12 IGKV1-9 IGKV1-5 IGKV2D-28 IGKV1D-39 IGKV1D-37 IGKV2-30 | 1.44e-12 | 142 | 104 | 10 | 5ba3a33c2ee20be8baaed97536ca6e9d1de6752f |
| ToppCell | 10x5'-blood-Lymphocytic_B_plasma|blood / Manually curated celltypes from each tissue | IGKV1-16 IGKV1-13 IGKV1-9 IGKV1-6 IGKV1-5 IGKV2D-40 IGKV2D-28 IGKV1D-43 IGKV1D-13 IGKV2-28 | 2.50e-12 | 150 | 104 | 10 | 6bab0a8bf78ed7de9e1b67ede7496488f80f4863 |
| ToppCell | 390C-Lymphocytic-Plasma_cell-|390C / Donor, Lineage, Cell class and subclass (all cells) | IGKV1-39 IGKV1-12 IGKV1-9 IGKV1-6 IGKV1-5 IGKV2D-28 IGKV1D-43 IGKV1D-33 IGKV1D-16 IGKV1D-8 | 3.70e-12 | 156 | 104 | 10 | 4f92ca30755430db44402afc603d1ecd8bfc3617 |
| ToppCell | 390C-Lymphocytic-Plasma_cell|390C / Donor, Lineage, Cell class and subclass (all cells) | IGKV1-39 IGKV1-12 IGKV1-9 IGKV1-6 IGKV1-5 IGKV2D-28 IGKV1D-43 IGKV1D-33 IGKV1D-16 IGKV1D-8 | 3.70e-12 | 156 | 104 | 10 | 0de2fc695bd5f8d4633c514f71ea941c88137bac |
| ToppCell | tumor_Lung-B_lymphocytes-Plasma_cells|tumor_Lung / Location, Cell class and cell subclass | IGKV1-27 IGKV1-12 IGKV1-9 IGKV1-6 IGKV1-5 IGKV2D-30 IGKV2D-29 IGKV2D-26 IGKV1D-39 IGKV2-30 | 8.23e-12 | 169 | 104 | 10 | b36b7632ce55fc7b6b8b66020563d360b3de6fd7 |
| ToppCell | Control-Lymphoid-B_Plasma|World / Disease state, Lineage and Cell class | IGKV1-39 IGKV1-13 IGKV1-12 IGKV1-5 IGKV2D-30 IGKV2D-26 IGKV1D-43 IGKV1D-39 IGKV1D-33 IGKV2-30 | 8.73e-12 | 170 | 104 | 10 | fb05f49b7113470995b3c16683c54dc1a660b73a |
| ToppCell | Plasma_cells|World / lung cells shred on cell class, cell subclass, sample id | IGKV1-39 IGKV1-16 IGKV1-12 IGKV1-9 IGKV1-6 IGKV1-5 IGKV2D-28 IGKV1D-39 IGKV1D-8 IGKV2-28 | 1.04e-11 | 173 | 104 | 10 | 52a387e2a4694af61a9223a4c2ecf4e6f762c064 |
| ToppCell | normal_Lymph_Node-B_lymphocytes-Plasma_cells|normal_Lymph_Node / Location, Cell class and cell subclass | IGKV1-27 IGKV1-17 IGKV1-12 IGKV1-6 IGKV1-5 IGKV2D-28 IGKV1D-39 IGKV1D-12 IGKV2-30 IGKV2-28 | 1.63e-11 | 181 | 104 | 10 | 949ac3b60e7fb5968da4c4e872965fb4e10f4a35 |
| ToppCell | 10x5'-Lung-Lymphocytic_B|Lung / Manually curated celltypes from each tissue | IGKV1-39 IGKV1-16 IGKV1-12 IGKV1-5 IGKV2D-28 IGKV1D-39 IGKV1D-33 IGKV1D-12 IGKV1D-8 IGKV2-29 | 1.72e-11 | 182 | 104 | 10 | 310f94437d197eaaaf6e30e68063b33e94befe77 |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_B_plasma-Plasma_cells|lymph-node_spleen / Manually curated celltypes from each tissue | IGKV1-17 IGKV1-13 IGKV1-9 IGKV1-5 IGKV2D-28 IGKV1D-39 IGKV1D-16 IGKV1D-13 IGKV1D-12 IGKV2-28 | 1.81e-11 | 183 | 104 | 10 | a6866951866373a1029e04818f4a4a31278c409d |
| ToppCell | Mild_COVID-19-B_cell|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | IGKV1-39 IGKV1-16 IGKV1-9 IGKV1-6 TLR9 IGKV1-5 IGKV1D-39 IGKV1D-8 IGKV2-30 IGKV2-29 | 1.81e-11 | 183 | 104 | 10 | dea119e2988e954475f557f0bbe12556a83e81a4 |
| ToppCell | BAL-Mild-Lymphocyte-B-B_cell-B_cell|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | IGKV1-39 IGKV1-16 IGKV1-12 IGKV1-9 IGKV1-6 TLR9 IGKV1-5 IGKV2D-28 IGKV1D-39 IGKV2-29 | 1.92e-11 | 184 | 104 | 10 | 3f8a359e40bebe58545f708682e5e5d1b70cf5cb |
| ToppCell | 10x5'-Liver-Lymphocytic_B_plasma-Plasma_cells|Liver / Manually curated celltypes from each tissue | IGKV1-39 IGKV1-27 IGKV1-17 IGKV1-13 IGKV1-12 IGKV1-9 IGKV2D-28 IGKV1D-39 IGKV1D-13 IGKV1D-12 | 1.92e-11 | 184 | 104 | 10 | 6f70d8f8ab8362d51f8a58735d42223e06566397 |
| ToppCell | BAL-Mild-Lymphocyte-B-B_cell-B_cell-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | IGKV1-39 IGKV1-16 IGKV1-12 IGKV1-9 IGKV1-6 TLR9 IGKV1-5 IGKV2D-28 IGKV1D-39 IGKV2-29 | 1.92e-11 | 184 | 104 | 10 | 64bede8db709fd32f40c03265b96f0b12155bb8a |
| ToppCell | BAL-Mild-Lymphocyte-B-B_cell|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | IGKV1-39 IGKV1-16 IGKV1-12 IGKV1-9 IGKV1-6 TLR9 IGKV1-5 IGKV2D-28 IGKV1D-39 IGKV2-29 | 2.02e-11 | 185 | 104 | 10 | 609080adb2cfb105bb7b8efb617553833299f371 |
| ToppCell | Mild_COVID-19-B_cell-B_cell|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | IGKV1-39 IGKV1-17 IGKV1-16 IGKV1-9 IGKV1-6 TLR9 IGKV1-5 IGKV1D-39 IGKV1D-8 IGKV2-29 | 2.13e-11 | 186 | 104 | 10 | 855a5a00ba2aa1b5c63b8db56d026ddecc546050 |
| ToppCell | 5'-Adult-LargeIntestine|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-9 IGKV1-6 IGKV1-5 IGKV1D-13 IGKV2-30 IGKV2-29 CA4 | 3.40e-11 | 195 | 104 | 10 | 600174e35574fe7c44dd923adcf43686e7b01e39 |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Lymphocytic-B-B_plasma|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | IGKV1-39 IGKV1-17 IGKV1-12 IGKV1-5 IGKV2D-28 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-13 IGKV1D-8 | 3.58e-11 | 196 | 104 | 10 | b3d5540fe8ab9a9cbb9ab5350f5cb0e1aae93584 |
| ToppCell | Tracheal-10x5prime-Immune_Lymphocytic-B-B_cell-B_naive|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | IGKV1-39 IGKV1-33 IGKV1-9 ANXA6 APOF IGKV2D-29 IGKV1D-33 IGKV1D-13 IGKV1D-8 IGKV2-29 | 3.76e-11 | 197 | 104 | 10 | fd65020089baca78334cecddc96b7a65028c2b7c |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-B-B_cell-B_mature|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | IGKV1-39 IGKV1-33 IGKV1-27 IGKV1-17 IGKV1-12 TLR9 IGKV1-5 IGKV1D-43 IGKV1D-39 IGKV2-29 | 3.95e-11 | 198 | 104 | 10 | d51ee880acc5804cd918105fac846a1528333d6c |
| ToppCell | 10x5'-blood-Lymphocytic_B_plasma-Plasma_cells|blood / Manually curated celltypes from each tissue | IGKV1-16 IGKV1-13 IGKV1-9 IGKV1-6 IGKV1-5 IGKV2D-40 IGKV1D-43 IGKV1D-13 IGKV2-40 | 6.99e-11 | 147 | 104 | 9 | 58089378fac1743ce99dc4f1bd7b5253a927f050 |
| ToppCell | 390C-Lymphocytic-Plasma_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | IGKV1-39 IGKV1-12 IGKV1-9 IGKV1-6 IGKV2D-28 IGKV1D-43 IGKV1D-33 IGKV1D-16 IGKV1D-8 | 2.07e-10 | 166 | 104 | 9 | 4ba3711a02d3695b27f7cefd7c60e3be009f5bef |
| ToppCell | 390C-Lymphocytic-Plasma_cell-|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | IGKV1-39 IGKV1-12 IGKV1-9 IGKV1-6 IGKV2D-28 IGKV1D-43 IGKV1D-33 IGKV1D-16 IGKV1D-8 | 2.07e-10 | 166 | 104 | 9 | 35f6ae2664935dda0d883b32a050ced843204f2d |
| ToppCell | Healthy-Plasmablast|Healthy / disease group, cell group and cell class | IGKV1-27 IGKV1-16 CHAD SLC2A4 IGKV1-5 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-8 | 3.67e-10 | 177 | 104 | 9 | 4ff75c609ac9edf7a94bda42eb7124c559e8b6aa |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 4.07e-05 | 50 | 42 | 4 | GAVISH_3CA_MALIGNANT_METAPROGRAM_10_PROTEIN_MATURATION | |
| Drug | 2,3-PDCA | 2.14e-06 | 8 | 78 | 3 | CID000127037 | |
| Disease | COMM domain-containing protein 1 measurement | 8.20e-06 | 2 | 85 | 2 | EFO_0802424 | |
| Disease | level of nuclear factor NF-kappa-B p105 subunit in blood serum | 8.20e-06 | 2 | 85 | 2 | OBA_2040323 | |
| Disease | vasculitis (is_implicated_in) | 4.90e-05 | 4 | 85 | 2 | DOID:865 (is_implicated_in) | |
| Disease | cystic fibrosis (is_implicated_in) | 6.42e-05 | 27 | 85 | 3 | DOID:1485 (is_implicated_in) | |
| Disease | ras-related protein Rab-26 measurement | 8.15e-05 | 5 | 85 | 2 | EFO_0801989 | |
| Disease | low tension glaucoma (implicated_via_orthology) | 8.15e-05 | 5 | 85 | 2 | DOID:13544 (implicated_via_orthology) | |
| Disease | epilepsy (implicated_via_orthology) | 1.11e-04 | 163 | 85 | 5 | DOID:1826 (implicated_via_orthology) | |
| Disease | episodic ataxia type 6 (implicated_via_orthology) | 1.22e-04 | 6 | 85 | 2 | DOID:0050994 (implicated_via_orthology) | |
| Disease | graft-versus-host disease (implicated_via_orthology) | 1.71e-04 | 7 | 85 | 2 | DOID:0081267 (implicated_via_orthology) | |
| Disease | tryptase beta-2 measurement | 2.91e-04 | 9 | 85 | 2 | EFO_0008306 | |
| Disease | beta-2 microglobulin measurement | 4.44e-04 | 11 | 85 | 2 | EFO_0005197 | |
| Disease | serum IgE measurement | 8.47e-04 | 64 | 85 | 3 | EFO_0004579 | |
| Disease | erythrocyte measurement | 8.97e-04 | 257 | 85 | 5 | EFO_0005047 | |
| Disease | cathepsin L1 measurement | 9.59e-04 | 16 | 85 | 2 | EFO_0010619 | |
| Disease | lupus nephritis (is_implicated_in) | 1.22e-03 | 18 | 85 | 2 | DOID:0080162 (is_implicated_in) | |
| Disease | COVID-19 (is_implicated_in) | 1.66e-03 | 21 | 85 | 2 | DOID:0080600 (is_implicated_in) | |
| Disease | cardiovascular system disease (is_implicated_in) | 1.66e-03 | 21 | 85 | 2 | DOID:1287 (is_implicated_in) | |
| Disease | Nerve Degeneration | 1.80e-03 | 83 | 85 | 3 | C0027746 | |
| Disease | C-peptide measurement | 1.82e-03 | 22 | 85 | 2 | EFO_0005187 | |
| Disease | Parkinson disease | 1.82e-03 | 22 | 85 | 2 | cv:C0030567 | |
| Disease | gastric carcinoma | 2.19e-03 | 89 | 85 | 3 | EFO_0000178 | |
| Disease | Brain Diseases | 2.36e-03 | 25 | 85 | 2 | C0006111 | |
| Disease | large artery stroke, coronary artery disease | 2.36e-03 | 25 | 85 | 2 | EFO_0001645, EFO_0005524 | |
| Disease | interstitial lung disease (is_marker_for) | 2.36e-03 | 25 | 85 | 2 | DOID:3082 (is_marker_for) | |
| Disease | Encephalopathies | 2.75e-03 | 27 | 85 | 2 | C0085584 | |
| Disease | glucose tolerance test | 2.75e-03 | 27 | 85 | 2 | EFO_0004307 | |
| Disease | hypertension, COVID-19 | 2.75e-03 | 27 | 85 | 2 | EFO_0000537, MONDO_0100096 | |
| Disease | factor VIII measurement, von Willebrand factor measurement | 2.75e-03 | 27 | 85 | 2 | EFO_0004629, EFO_0004630 | |
| Disease | acute kidney failure (implicated_via_orthology) | 2.75e-03 | 27 | 85 | 2 | DOID:3021 (implicated_via_orthology) | |
| Disease | chronic obstructive pulmonary disease (is_marker_for) | 2.80e-03 | 97 | 85 | 3 | DOID:3083 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SILLLFLLMMLGVRG | 91 | Q96D05 | |
| GLVLAMAMLKLLRPS | 941 | Q8IZF5 | |
| MALVPCQVLRMAILL | 1 | Q9NVV5 | |
| ALRPMILFLIMLVLV | 16 | P16442 | |
| MERMLPLLALGLLAA | 1 | P01011 | |
| DMRGLRLIMIPVELL | 11 | Q13790 | |
| PRKGLLMLLMALVTQ | 6 | P37023 | |
| MVRPMLLLSLGLLAG | 1 | O15335 | |
| IMKAMVPLLQIGLLL | 216 | Q00975 | |
| ISGDLARLILGLMMP | 421 | P08133 | |
| DIQMAVRLLLPGKMG | 116 | P0C1H6 | |
| QLLLNLLEMMLYAGL | 1111 | O75747 | |
| MVLMAPRTLLLLLSG | 1 | P01893 | |
| MRLPAQLLGLLMLWI | 1 | A0A075B6S2 | |
| DLLRMIVMGKNLGIP | 616 | Q6TGC4 | |
| MRLPAQLLGLLMLWV | 1 | P01614 | |
| MRLPAQLLGLLMLWV | 1 | A0A075B6S6 | |
| MDMRVPAQLLGLLLL | 1 | P01593 | |
| MDMRVPAQLLGLLLL | 1 | P04432 | |
| PAMLLISLLLAAGLM | 16 | Q6ZSA7 | |
| MDMMVPAQLLGLLLL | 1 | P01611 | |
| MILIPRMLLVLFLLL | 1 | Q16832 | |
| LMTVALLLLERVPAM | 366 | P14672 | |
| MDMRVPAQRLGLLLL | 1 | A0A0B4J1Z2 | |
| LGLLLLPILAMLMAL | 11 | O43561 | |
| MRLPAQLLGLLMLWV | 1 | P01615 | |
| MDMRVPAQLLGLLLL | 1 | P0DSN7 | |
| LLPLRLALLDEMMSD | 256 | Q8NHP7 | |
| MIVLVMLLNIGLAIL | 641 | Q9HDC5 | |
| MDMRVPAQLLGLLLL | 1 | A0A087WSZ0 | |
| MDMRVPAQLLGLLLL | 1 | A0A0B4J2D9 | |
| MQMIPVGLLGRDILA | 231 | Q5T1V6 | |
| MLRARPEALMLLGAL | 1 | Q9NRD8 | |
| LLTMILFLGPLMQLS | 121 | Q9Y256 | |
| MRVMAPRALLLLLSG | 1 | P10321 | |
| PRLAAMMLLQLLEGV | 336 | Q9BXM7 | |
| MRLPAQLLGLLMLWV | 1 | A0A0A0MRZ7 | |
| LMRGFMSILPIILSL | 146 | Q9Y5P0 | |
| VMRIGLDLPALNMQR | 576 | P05164 | |
| IIMILNGEKLPGLLM | 46 | P53618 | |
| ILVMLGLLSSILMQL | 386 | Q9H295 | |
| MDMRVPAQLLGLLLL | 1 | A0A075B6S4 | |
| LAAGIRPRMLVMELA | 1936 | Q5S007 | |
| MPMANLLLLIVPILI | 1 | P03886 | |
| MLLIIRLDLQLHTPM | 46 | Q8N146 | |
| NRLSRLLKPGGMMLL | 276 | Q96IZ6 | |
| LSGRPLMLLATALKM | 231 | O75864 | |
| MRMLLALLALSAARP | 1 | P22748 | |
| GGLILVLLIMLALRM | 161 | Q13145 | |
| ELLMRMLQMLVLPLI | 86 | P43003 | |
| MVEPLQAILIRMLLR | 151 | Q13617 | |
| MAVMAPRTLLLLLSG | 1 | P04439 | |
| MLRMRVPALLVLLFC | 1 | Q6UWL6 | |
| MDMRVPAQLLGLLLL | 1 | P01602 | |
| MDMRVPAQLLGLLLL | 1 | A0A0C4DH72 | |
| MDMRVPAQLLGLLLL | 1 | A0A0C4DH69 | |
| MDMRVPAQLLGLLLL | 1 | A0A0C4DH73 | |
| MDMRVPAQLLGLLLL | 1 | P0DP09 | |
| MDMRVLAQLLGLLLL | 1 | P04430 | |
| MDMRVPAQLLGLLLL | 1 | P01599 | |
| MDMRVPAQLLGLLLL | 1 | A0A075B6S5 | |
| MDMRVPAQLLGLLLL | 1 | P01594 | |
| MDMRVPAQLLGLLLL | 1 | A0A075B6S9 | |
| MDMRVPAQLLGLLLL | 1 | P01597 | |
| MRLPAQLLGLLMLWV | 1 | A0A075B6P5 | |
| MRLPAQLLGLLMLWI | 1 | A2NJV5 | |
| MRLPAQLLGLLMLWV | 1 | P06310 | |
| MRLPAQLLGLLMLWV | 1 | A0A087WW87 | |
| RMEMLCAGRVPALLL | 6 | O14944 | |
| PLSMLIAMGALLLCL | 91 | P56749 | |
| MELVRRLMPLTLLIL | 1 | Q86UP6 | |
| MRILVTLLLDTLPML | 216 | O95180 | |
| RTGLLMNLMGVLLLS | 546 | Q8WWT9 | |
| GLPAMLQAVRALMIV | 71 | P56856 | |
| MLLFALLLAMELPLV | 1 | Q99445 | |
| GEILMRMLKLIILPL | 56 | P43005 | |
| MMSLGVLNLARLPVL | 266 | Q8N9I5 | |
| MGELMAFLLPLIIVL | 1 | Q95460 | |
| IMILSQGLQTLLPLM | 341 | P03905 | |
| MLLLAPQMLSLLLLA | 1 | Q9BZJ3 | |
| LRGATALEMGMPLLL | 201 | Q5UIP0 | |
| LELMPQGLRGLMLSV | 371 | Q9NY91 | |
| LELLPTGLRGLMMAV | 366 | Q8WWX8 | |
| PMHIDRNILMLILPL | 136 | Q5PT55 | |
| NLGLMALDPMELRIV | 276 | Q9H8M5 | |
| GLNLGLMALDPMELR | 201 | Q6P4Q7 | |
| PLNYALLLIGMMITR | 701 | Q99973 | |
| MAAAMPLALLVLLLL | 1 | Q969N2 | |
| VKLMPNGLRGLMLAV | 371 | P31639 | |
| PLARLPMLQTLRLQM | 386 | Q9NR96 | |
| VSVMPMLLLALLLLL | 166 | Q12893 | |
| GLVAGLSLMMILRLV | 81 | Q9Y6G1 | |
| LLGAMLLSMALQLDR | 326 | A6NDV4 | |
| ALVMLLEVRMDRLLP | 246 | Q92973 | |
| PLDLLDRVMIIRTML | 351 | Q9Y265 | |
| IRGMGMNSPELLLLV | 831 | Q92797 | |
| SLLMLMDSPLNRAGL | 91 | Q92979 | |
| FLLGILLMLDVMIII | 206 | Q96CP7 | |
| MVRMVPVLLSLLLLL | 1 | P25311 | |
| LALLLTLPVMLAMRL | 176 | Q9UKP6 | |
| LLLLMVLMLGRVLVV | 6 | Q96RP3 | |
| RGIRTLLFALMMSLP | 1481 | Q9UI33 | |
| MLLLLIPVLGMIFAL | 1 | A0A0A6YYK1 | |
| LLGIALELGLQVMRM | 666 | Q9H7M6 | |
| MDMRVLAQLLGLLLL | 1 | P01601 | |
| MDMRVPAQLLGLLLL | 1 | A0A075B6H8 |